Amedeo Smart

Free Medical Literature Service

 

Amedeo

Breast Cancer
  Free Subscription

Articles published in
PLoS One
    January 2026
  1. ZHAO X, Li J, Hu N, Wu X, et al
    Establishment of an amino acid metabolism related signature for prognostic and therapeutic sensitivity prediction in breast cancer by machine learning.
    PLoS One. 2026;21:e0340586.
    >> Share

  2. FERRE F, Seghieri C, Sarv Ahrabi S, Burattin A, et al
    Enhancing quality and decision-making for care pathways: An application of process mining in cancer care.
    PLoS One. 2026;21:e0339788.
    >> Share

  3. LI J, Zhao B, Chen Y, Wang G, et al
    Research on the establishment of a four-classification model for breast mass ultrasound images based on transfer learning.
    PLoS One. 2026;21:e0340111.
    >> Share


  4. Retraction: Phospho-Aspirin-2 (MDC-22) Inhibits Estrogen Receptor Positive Breast Cancer Growth Both In Vitro and In Vivo by a Redox-Dependent Effect.
    PLoS One. 2026;21:e0341199.
    >> Share

  5. LIU C, Ren Y, Luo X, Zhou P, et al
    Inhibition of HER2 signaling and breast cancer cell growth with a novel antibody targeting HER2 ECD III/IV.
    PLoS One. 2026;21:e0338127.
    >> Share

  6. YU H, Zhao J, Wu D, Yuan H, et al
    Exosome encapsulated albumin nanoparticles target delivery of DBET6 as a treatment for triple-negative breast cancer.
    PLoS One. 2026;21:e0335890.
    >> Share

  7. POELHEKKEN K, Greuter MJW, Dorrius MD, de Bock GH, et al
    Influence of follow-up, screening age, interval, and compliance on overdiagnosis of ductal carcinoma in situ (DCIS): A modelling study.
    PLoS One. 2026;21:e0331821.
    >> Share

  8. FILIPOV T, Teutsch B, Vass D, Budinszki B, et al
    Cryoablation for fibroadenoma with liquid nitrogen based system: A retrospective analysis of prospectively collected data.
    PLoS One. 2026;21:e0340969.
    >> Share


  9. Retraction: Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug.
    PLoS One. 2026;21:e0341297.
    >> Share

  10. CHAVDA T, Lawal A, Sowunmi A, Adegboyega B, et al
    Validation and limitations of the distress thermometer in identifying depression among metastatic breast cancer patients in Nigeria: Methodological challenges in depression-specific screening validation.
    PLoS One. 2026;21:e0341221.
    >> Share

  11. YE L, Yu G, Cheng Y, Fan L, et al
    DnaK supports intracellular persistence of Staphylococcus xylosus and confers mechanical resilience to a human breast cancer cell line.
    PLoS One. 2026;21:e0341069.
    >> Share

  12. YING K, Xue H, Du S, Wang X, et al
    Zwitterionic molecularly imprinted polymers for selective capillary microextraction of N1,N12-Diacetylspermine (DiAcSpm) from breast cancer.
    PLoS One. 2026;21:e0339776.
    >> Share

  13. KUMAR ARK, Shaji CS, Rajagopalan A, Bhattacharya S, et al
    Increased sensitivity of etoposide-treated breast cancer cells with an ATM inhibitor.
    PLoS One. 2026;21:e0340472.
    >> Share

  14. MAHAR B, Osman MB, Fauzi FA
    From awareness to action: Health Belief Model-based educational intervention to improve breast self-examination practice among college teachers in Pakistan (CRCT).
    PLoS One. 2026;21:e0341804.
    >> Share

  15. YANG C, Li Z, Li G, Mi H, et al
    Exploring the relationship between metabolism and immune microenvironment in breast cancer bone metastasis based on metabolic pathways.
    PLoS One. 2026;21:e0341270.
    >> Share

  16. YANG DD, Liu CH, Jia SQ, Xue ZK, et al
    RUBCN as a novel prognostic biomarker and therapeutic target in breast cancer.
    PLoS One. 2026;21:e0341357.
    >> Share

  17. HE L, Hu H, Cheng R
    Breast cancer histopathological image classification based on collaborative multi-domain feature learning.
    PLoS One. 2026;21:e0341320.
    >> Share

  18. CAZAGRANDA IC, de Almeida RF, Smaniotto LL, de Andrade Berny MP, et al
    Hidden risks associated with occupational pesticide exposure in women with breast cancer: High frequency of the Luminal B molecular subtype and occurrence of poor prognostic features.
    PLoS One. 2026;21:e0339471.
    >> Share

  19. MOHAMMAD HUSSIN N, Nik Jaafar NR, Idris IB, Mohammed Nawi A, et al
    Mental health help-seeking among individuals with breast cancer: A qualitative exploration of women's and healthcare practitioners' perspectives.
    PLoS One. 2026;21:e0342002.
    >> Share

  20. STINTON S, Edwick D, Maxwell-Smith C, Bear N, et al
    Evaluating the effect of the SMART intervention in people with recently diagnosed breast cancer who are being treated at a public tertiary hospital in Australia: protocol and statistical analysis plan for a single-blinded, single centre randomised con
    PLoS One. 2026;21:e0341423.
    >> Share

  21. SANCHEZ-SALDANA L, Lozada-Urbano M, Sullcahuaman-Allende Y, Cotrina-Concha J, et al
    Anthropometric and biochemical nutritional indicators and survival in women with breast cancer: A retrospective cohort study.
    PLoS One. 2026;21:e0341500.
    >> Share

  22. WANG Y, Feng L, He L, Liu N, et al
    Al18F-NOTA-FAPI-04 PET/CT for diagnosis of breast cancer and its correlation with pathological features: A single-center retrospective study.
    PLoS One. 2026;21:e0342769.
    >> Share


  23. Expression of Concern: Tumor Associated Macrophage x Cancer Cell Hybrids May Acquire Cancer Stem Cell Properties in Breast Cancer.
    PLoS One. 2026;21:e0342526.
    >> Share

  24. FATHIMATHUL RAJEENA PP, Yasir M, Ali MAS, Khan JA, et al
    Breast cancer inter-image dissimilarity by feature optimization: An application of novel flea optimization algorithm.
    PLoS One. 2026;21:e0341848.
    >> Share

  25. ZHOU R, Yu X, Wang J
    High accuracy breast cancer classification with BIRADS and coclustering.
    PLoS One. 2026;21:e0340772.
    >> Share

  26. ALQAHTANI S, Alqahtani K, Alshomrani F, AlQahtani K, et al
    AdaptiveInvolutionNet: Spatially-adaptive involution with channel-wise attention for breast MRI tumor classification.
    PLoS One. 2026;21:e0340808.
    >> Share

  27. XU F, Xie S, Li Q, Zhong X, et al
    The effect of self-concealment on post-traumatic stress symptoms in breast cancer patients: The mediating role of experiential avoidance.
    PLoS One. 2026;21:e0342971.
    >> Share


  28. Expression of Concern: Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway.
    PLoS One. 2026;21:e0343779.
    >> Share

  29. TU C, Zhong Y, Li H, Qi H, et al
    A cost-effective breast cancer screening strategy for Urban China: Findings from a Shenzhen-based modeling study.
    PLoS One. 2026;21:e0344253.
    >> Share

  30. SUNG J, Song G, Jeong I, Ha J, et al
    Dosimetric benefits of 1.5 T MR-guided radiotherapy in partial breast treatment.
    PLoS One. 2026;21:e0342973.
    >> Share

  31. SAKSORNCHAI K, Tawonwong T, Oonsiri P, Vimolnoch M, et al
    Dosimetric comparison study of ultrahypofractionated photon versus proton treatment plans in post breast-conserving surgery breast cancer.
    PLoS One. 2026;21:e0344699.
    >> Share

  32. MYERS SP, Tsung C, Chen JC, Gokun Y, et al
    Factors correlated with financial hardship among cancer patients during the COVID-19 pandemic.
    PLoS One. 2026;21:e0342984.
    >> Share

  33. ABUHIJLEH H, Zakria Z, Bawadi H, Hammad A, et al
    Unraveling the therapeutic potential of Elaeagnus angustifolia extract on triple-negative breast cancer (TNBC): An investigation using zebrafish model.
    PLoS One. 2026;21:e0344247.
    >> Share

  34. KANG S, Yang S, Jia Y, Zhao S, et al
    Cost-effectiveness of sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer in China.
    PLoS One. 2026;21:e0343330.
    >> Share

  35. JAVED S, Javed U, Mohamed Noor DA, Hanafiah NHM, et al
    Glycemic trajectories of fasting blood glucose on the pathological responses in breast cancer women with and without concomitant diabetes.
    PLoS One. 2026;21:e0319314.
    >> Share

  36. ALIPOUR S, Jafari K, Saberi A, Motamedi M, et al
    What is the significance of a new breast mass in women aged 40 or above? A cross-sectional study.
    PLoS One. 2026;21:e0341732.
    >> Share

  37. RAFI MSH, Millat MS, Barek MA, Dewan SMR, et al
    Association of NUDT17 rs9286836 and rs2004659 variants with breast cancer risk in Bangladeshi Women.
    PLoS One. 2026;21:e0344584.
    >> Share

  38. SIAM MBH, Khan MR, Elahe MF, Arman MS, et al
    Effects of similarity networks in graph-based multi-omics classification.
    PLoS One. 2026;21:e0344754.
    >> Share

  39. JENA M, Dehuri S, Cho SB
    SGA-DT: An adaptive fusion framework for missing data imputation and interpretable healthcare classification.
    PLoS One. 2026;21:e0343619.
    >> Share

  40. DAY S, Harries J, Sawula B, Payne A, et al
    Navigating cancer: Insights from patient journey mapping.
    PLoS One. 2026;21:e0327113.
    >> Share

  41. AHMAD S, Qazi S, Bano N, Uddin R, et al
    Multitarget docking and molecular enumeration reveal DdpMPyPEPhU as a potent modulator of cell cycle, glucocorticoid, and estrogen signalling in breast cancer.
    PLoS One. 2026;21:e0344028.
    >> Share

  42. LI Y, Chong M, Chui P, Mo L, et al
    Navigating parenting challenges: A qualitative study of communication experiences among young Chinese couples facing breast cancer while raising underage children.
    PLoS One. 2026;21:e0345543.
    >> Share

  43. CHIANG PY, Huang PJ, Hung CH, Lin CP, et al
    Deep inspiration breath hold versus free breathing in postoperative radiotherapy strategy for patients with left-sided breast cancer treated with volumetric modulated arc therapy: A meta-analysis and systematic review.
    PLoS One. 2026;21:e0345614.
    >> Share

  44. LYU J, Wang E, Lyu S, Qian Y, et al
    JMJD3 regulates the M2-like macrophage polarization and promotes the growth of breast cancer cells via STAT6/IRF4 axis.
    PLoS One. 2026;21:e0341313.
    >> Share

  45. AKRAM L, Abbas G, Khurram H, Aslam A, et al
    Association of marital and parental status with stress, support, adherence, and quality of life among breast cancer women.
    PLoS One. 2026;21:e0346016.
    >> Share


  46. Retraction: 3, 3'-diindolylmethane Enhances the Effectiveness of Herceptin against HER-2/Neu-Expressing Breast Cancer Cells.
    PLoS One. 2026;21:e0346218.
    >> Share

  47. YANG J, Qu S, Qi X, Liu Y, et al
    The PD-1 and CD28 molecules on T cells in peripheral blood are associated with the prognosis of patients with advanced breast cancer receiving paclitaxel chemotherapy.
    PLoS One. 2026;21:e0344366.
    >> Share

  48. WANG Y, Zou Z, Wu Y, Chen J, et al
    Multi-task adaptive deep sparse canonical correlation analysis for multi-omics cancer survival prediction.
    PLoS One. 2026;21:e0346274.
    >> Share


  49. Expression of Concern: Targeting necroptosis in MCF-7 breast cancer cells: In Silico insights into 8,12-dimethoxysanguinarine from Eomecon Chionantha through molecular docking, dynamics, DFT, and MEP studies.
    PLoS One. 2026;21:e0347090.
    >> Share

  50. RANI H, Mehmood T, Aslam M, Al-Essa LA, et al
    Unveiling the Multifaceted Dynamics of Breast Cancer: A Copula Regression Approach to Modeling and Predicting Outcomes.
    PLoS One. 2026;21:e0346495.
    >> Share

  51. RUJIMONGKON K, Adchariyasakulchai P, Boonyaratsewee C, Horpratraporn K, et al
    Ivermectin inhibits ER, HER2, and TGF-beta pathways in ER-positive and endocrine-resistant breast cancer cells.
    PLoS One. 2026;21:e0348260.
    >> Share

  52. LAZA-VASQUEZ C, Roman M, Delaloge S, De Montgolfier S, et al
    "Unanswered questions": Acceptability of a personalised breast cancer screening strategy in lower-risk women by healthcare professionals in the context of the MyPeBS study.
    PLoS One. 2026;21:e0347029.
    >> Share

  53. COLWELL S, Chalise P, Gajewski B, Ratnayake I, et al
    Spatial and temporal modeling of breast cancer mortality in Kansas: An R-INLA approach.
    PLoS One. 2026;21:e0347607.
    >> Share


  54. Retraction: Chemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy.
    PLoS One. 2026;21:e0348849.
    >> Share

  55. SIAME C, Ofori B, Paemka LA, Danquah KO, et al
    In silico evaluation of garlic-derived organosulfur compounds as multi-target inhibitors of breast cancer biomarkers.
    PLoS One. 2026;21:e0348369.
    >> Share

  56. RAJAMOHAN HR, Xu Y, Zhu W, Kijowski R, et al
    Robust disease prognosis via diagnostic knowledge preservation: A sequential learning approach.
    PLoS One. 2026;21:e0344600.
    >> Share

  57. SASAKI T, Torii S
    Node properties of biomarkers within the protein-protein interaction network derived from breast cancer-associated genes.
    PLoS One. 2026;21:e0347551.
    >> Share

  58. ALY IBRAHIM AA, Darwish MY, El-Farargy SH, Saad NE, et al
    Exploring socio-demographic determinants of breast self-examination practices among Jordanian women: insights from the 2023 population-based survey.
    PLoS One. 2026;21:e0347331.
    >> Share

  59. WALYELDEEN AA, Mohamed G, Taha SN, Gameel AM, et al
    Plasma small-extracellular vesicles' proteomic signature in neoadjuvant chemotherapy-naive breast cancer patients.
    PLoS One. 2026;21:e0348500.
    >> Share

  60. HWANGBO S, Choi Y, Ryu JY
    Development of predictive models for the prognosis of triple-negative breast cancer using multiple transcriptomic analyses.
    PLoS One. 2026;21:e0348414.
    >> Share

  61. JAMADAR IS, Kumar K, Khan A, Khan SA, et al
    Optimizing breast cancer treatment strategies through fractional-order dynamics: A computational modeling approach.
    PLoS One. 2026;21:e0347160.
    >> Share

  62. CHAUVIN P, Huet T, Gligorov J, Sargent C, et al
    Social disparities in the frequency and severity of triple-negative breast cancer at diagnosis in a university hospital in Paris, France: confronting race and ethnic blindness.
    PLoS One. 2026;21:e0349041.
    >> Share

  63. FUENTES-EXPOSITO MA, Frid S, Munoz-Mateu M, Siso-Almirall A, et al
    Feasibility of the Xemio app for breast cancer survivors in a clinical setting: Adherence, acceptance, and side effect monitoring (CTCAE vs. QoL).
    PLoS One. 2026;21:e0342702.
    >> Share

  64. AQUINO LCM, Andrade EIS, Nunes LMF, Santos EM, et al
    Analysis of tumor-infiltrating lymphocytes as prognostic factor in triple-negative breast cancer: A protocol of systematic review and meta-analysis.
    PLoS One. 2026;21:e0342085.
    >> Share

  65. LI Y, Chen Y, Xu C, Zhan W, et al
    An exploratory dosimetric and treatment-time analysis of tangent-arc and continuous semi-arc VMAT in deep inspiration breath-hold radiotherapy for stage I left-sided breast cancer.
    PLoS One. 2026;21:e0348570.
    >> Share

  66. STAYOUSSEF M, Habel A, Xu W, Bessaad M, et al
    Multiplex profiling of 16 immune checkpoints identifies novel serum biomarker panels for breast cancer detection and TNBC stratification: A case-control study.
    PLoS One. 2026;21:e0348953.
    >> Share

  67. MUKHERJEE A, Goyal P, Tripathi R, Goyal S, et al
    Real world experience with cyclin dependent kinase inhibitors in metastatic breast cancer in India.
    PLoS One. 2026;21:e0349196.
    >> Share

  68. LI H, Huang J, Hou J, Chen X, et al
    Machine learning models based on magnetic resonance imaging for predicting Lymphovascular Invasion in Invasive Breast Cancer.
    PLoS One. 2026;21:e0350085.
    >> Share

  69. BARATI T, Moghaddam MM, Mokhles F, Mirzaei Z, et al
    Comprehensive multi-omics analysis reveals prognostic, immune, and therapeutic signatures of TNFAIP family genes in breast cancer.
    PLoS One. 2026;21:e0349012.
    >> Share

  70. CHUNG EZ, Alberico D, Sannachi L, Dasgupta A, et al
    Early tumour size changes from neoadjuvant chemotherapy as a predictor of pathologic response in breast cancer.
    PLoS One. 2026;21:e0346704.
    >> Share

  71. PATASOVA K, Che WI, Westerlind H, Diaz-Gallo LM, et al
    Local genetic correlations between systemic sclerosis and common cancer types.
    PLoS One. 2026;21:e0350006.
    >> Share

  72. TVETE IF, Klemp M
    Temporal dynamics of prognostic factors in breast cancer survival.
    PLoS One. 2026;21:e0349115.
    >> Share

  73. OMORI K, Furukawa K, Usubuchi M, Hamada T, et al
    A multicenter, randomized, parallel-group confirmatory study protocol to evaluate the efficacy of Soft Protector CPC, a novel oral mucosal protectant, in preventing oral mucositis and alleviating pain in patients with breast cancer.
    PLoS One. 2026;21:e0350803.
    >> Share

  74. AL-DAMOOK N, Sakkal M, Khair M, Mousa WK, et al
    Mapping metabolic reprogramming in lung and breast cancer through integrative bioinformatics.
    PLoS One. 2026;21:e0350628.
    >> Share

  75. SOLIMAN SSM, Alhamidi TB, Abdin S, Almehdi AM, et al
    Correction: Effective targeting of breast cancer cells (MCF7) via novel biogenic synthesis of gold nanoparticles using cancer-derived metabolites.
    PLoS One. 2026;21:e0350791.
    >> Share

  76. ZHENG L, Li W, Wang B, Wu T, et al
    Identification of potential key genes that respond to capsaicin treatment in ER-positive breast cancer: An integrated analysis.
    PLoS One. 2026;21:e0350841.
    >> Share

  77. YANG W
    Tumor hypoxia is associated with global copy-number alteration burden and subtype-dependent overall survival in breast cancer: Evidence from TCGA and METABRIC.
    PLoS One. 2026;21:e0350829.
    >> Share

  78. SCHOUTEN AEM, Frederix GWJ, Stuiver MM, Fischer F, et al
    Choice and impact of EQ-5D-5L value set in cost-utility analyses alongside multinational trials: Insights from PREFERABLE-EFFECT and CONVINCE.
    PLoS One. 2026;21:e0350019.
    >> Share

  79. NARASIMHAN RM, Saini AS, Samimi K, Ogobuiro I, et al
    Postmastectomy radiotherapy in pN1 breast cancer: Survival outcomes and prognostic factors from a single-institution cohort.
    PLoS One. 2026;21:e0341754.
    >> Share

  80. SARKER H, Farid FB, Kamrun M, Masud E, et al
    Multi-omics and pan-cancer analysis revealed common molecular signatures to disclose multitargeted anticancer agents through network pharmacology approach.
    PLoS One. 2026;21:e0350614.
    >> Share

  81. ARAFAT HM, Tengku Din TADA, Shafii N, Muhamad R, et al
    Interplay of the IGFBP-3 polymorphism and serum levels of IGF-1/IGFBP-3 with hormone receptor subtypes in patients with breast cancer among Palestinian women.
    PLoS One. 2026;21:e0350553.
    >> Share

  82. MANKELOW KA, O'Connor S, Santin O, Blackburn NE, et al
    Digital exercise interventions to improve physical functioning of people with breast cancer: Protocol for a scoping review.
    PLoS One. 2026;21:e0350300.
    >> Share

  83. EKPO IA, Ovenseri AC, Abdullateef A, Durmaz B, et al
    Formulation of 5-fluorouracil loaded chitosan-based nanoparticles and evaluation of its cytotoxic effects against MCF-7 human breast cancer cells.
    PLoS One. 2026;21:e0350929.
    >> Share

  84. ALAM R, Akter S, Mohammad T, Rini R, et al
    Knowledge of breast cancer and practice of breast self-examination among adolescent girls in semi-urban area - Savar, Dhaka, Bangladesh: A school-based cross-sectional study.
    PLoS One. 2026;21:e0334375.
    >> Share

  85. CHEN S, Yang X, Jiang S, Lin Y, et al
    Burden and temporal trends of female-specific cancers in China: A systematic analysis of the 2023 global burden of disease study.
    PLoS One. 2026;21:e0351539.
    >> Share

  86. NDENGUE CP, Atangana PJA, Ateba GR, Mandengue SH, et al
    Pre-analytical variables affecting breast cancer biomarker expression: A controlled single-specimen study of fixation duration, cold ischemia time, and fixative preparation in a low-resource setting.
    PLoS One. 2026;21:e0343185.
    >> Share

  87. EBERLE JV, Bickelhaupt S, Kapsner LA, Ohlmeyer S, et al
    Finite sample size errors in the context of multiple error sources in quantitative medical imaging: An evaluation for breast magnetic resonance diffusion-weighted imaging.
    PLoS One. 2026;21:e0341201.
    >> Share

  88. KHALIFA M, Soliman M, Omar A, Abouegylah M, et al
    Thyroid V40 as a potential early predictor of hypothyroidism following hypofractionated locoregional breast radiotherapy.
    PLoS One. 2026;21:e0351856.
    >> Share

  89. ZHENG LW, Liu YM, Yu KD, Liu CC, et al
    A fusion-deletion genomic-event underlies poor prognosis in young patients with luminal breast cancer.
    PLoS One. 2026;21:e0349410.
    >> Share

  90. KOUAME JM, Kouakou C, Gnanou S, Yacouba B, et al
    Markov modeling in R: Advanced method using a cost-effectiveness analysis.
    PLoS One. 2026;21:e0350698.
    >> Share

  91. NDUKA IJ, Okafor CE, Ekwunife OI
    Cost-effectiveness analysis of mammography screening for early detection of breast cancer in Nigeria.
    PLoS One. 2026;21:e0351492.
    >> Share

  92. KHAN MM, Hossain MA, Zohora F, Sohel M, et al
    In silico screening and molecular analyses identify apigenin from Scutellaria barbata as a potent AKT1 inhibitor in breast cancer.
    PLoS One. 2026;21:e0338874.
    >> Share

  93. PHETDEE C, Naephrai S, Pradain M, Panporm Y, et al
    Synergistic anticancer activity of antimicrobial peptide nisin and doxorubicin against breast cancer cells via modulation of membrane permeability.
    PLoS One. 2026;21:e0352312.
    >> Share


  94. Retraction: Biogenic green synthesis of MgO nanoparticles using Saussurea costus biomasses for a comprehensive detection of their antimicrobial, cytotoxicity against MCF-7 breast cancer cells and photocatalysis potentials.
    PLoS One. 2026;21:e0351977.
    >> Share

  95. CHENG Y, Jiang YN, Zhang Q
    Navigating ethical waters: The impact of ethical judgment, norms, and CSR skepticism on CSR engagement and purchasing intention in a breast cancer campaign.
    PLoS One. 2026;21:e0352994.
    >> Share


  96. Editorial Note: Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.
    PLoS One. 2026;21:e0352941.
    >> Share

  97. MOHTAR MA, Fessart D, Yuh Cai C, Zahari S, et al
    Genetic regulatory axis between AGR2 and ESR1 promotes breast cancer progression.
    PLoS One. 2026;21:e0351873.
    >> Share

  98. ISHII H, Nishiyama K, Nakahara A, Tamori S, et al
    Cell-cell junction gene signatures as subtype-specific prognostic biomarkers in breast cancer.
    PLoS One. 2026;21:e0352254.
    >> Share

  99. GRUNFELD AM, Bokros M, Paz K, Bilbao D, et al
    Amyloid-bodies in the evolution of malignancies.
    PLoS One. 2026;21:e0353464.
    >> Share

  100. HOVDA T, Sober S, Padrik P, Kruuv-Kao K, et al
    A clinical pilot study for personalized risk-based breast cancer screening utilizing a polygenic risk score.
    PLoS One. 2026;21:e0345431.
    >> Share

  101. SONG SG, Cho SI, Sim T, Shin S, et al
    Artificial intelligence-detected HER2 strong-positive tumor proportion predicts FISH positivity and treatment response in breast cancer.
    PLoS One. 2026;21:e0352979.
    >> Share

  102. NGUYEN V, Pham TV, Dinh TH, Tran DN, et al
    Age and tumor size as independent predictors of malignancy in BI-RADS 4 and 5 breast lesions: A cross-sectional study in Vietnam.
    PLoS One. 2026;21:e0352690.
    >> Share


  103. Correction: Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
    PLoS One. 2026;21:e0352946.
    >> Share

  104. NIE S, Liu D, Hu J, Gan Y, et al
    TBX20 promotes doxorubicin resistance in breast cancer cells through enhanced ABCC1 expression and inhibition of mitophagy.
    PLoS One. 2026;21:e0353376.
    >> Share

  105. MAENPAA N, Tiainen L, Martikainen J, Tanner M, et al
    Real-world implementation and cost impact analysis of Oncotype DX testing in early-stage breast cancer.
    PLoS One. 2026;21:e0353941.
    >> Share

  106. RAO NT, Ramana CVV, Karim FK, Aljarbouh A, et al
    ViT-MultiRAGNet: A scalable and reliable retrieval-augmented Vision Transformer framework for memory-guided feature fusion multi-modal mammogram classification.
    PLoS One. 2026;21:e0349865.
    >> Share

  107. ARAFAT HM, Ali A, Tengku Din TADAA, Shamallakh OM, et al
    Diagnostic accuracy of circulating microRNAs and lipidomic biomarkers for early breast cancer detection: A systematic review and meta-analysis.
    PLoS One. 2026;21:e0354728.
    >> Share

  108. STEPANIAN J, Mejia-Garcia A, Orozco C, Duitama J, et al
    Breast cancer clustering integrating complete gene expression profiles and genetic ancestry.
    PLoS One. 2026;21:e0352514.
    >> Share

  109. GRIBAUDO G, Fornari C, Antonazzo IC, Generali D, et al
    Decision tree model to assess consequences and costs associated with therapy administration pathways for patients with HER2+ breast cancer in Italian oncological centers.
    PLoS One. 2026;21:e0351548.
    >> Share

  110. LIU Y, Cao WM, Jin Y, Xu W, et al
    Single-cell transcriptomic analysis reveals the immunosuppressive status of NK cell subpopulations in TNBC.
    PLoS One. 2026;21:e0354524.
    >> Share


  111. Correction: miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5.
    PLoS One. 2026;21:e0354115.
    >> Share

    January 2025
  112. SHABO I, Midtbo K, Branstrom R, Lindstrom A, et al
    Monocyte-cancer cell fusion is mediated by phosphatidylserine-CD36 receptor interaction and induced by ionizing radiation.
    PLoS One. 2025;20:e0311027.
    >> Share

  113. WANNUME H, Niyonzima N, Kalungi S, Okuni JB, et al
    Quantitative expression of estrogen, progesterone and human epidermal growth factor receptor-2 and their correlation with immunohistochemistry in breast cancer at Uganda Cancer Institute.
    PLoS One. 2025;20:e0311185.
    >> Share

  114. KIM H, Park H, Chun Y, Kim H, et al
    Prognostic significance of total choline on in-vivo proton MR spectroscopy for prediction of late recurrence in patients with hormone receptor-positive, HER2-negative early breast cancer.
    PLoS One. 2025;20:e0311012.
    >> Share

  115. TAKANO EA, Jana MK, Lara Gonzalez LE, Pang JB, et al
    Preliminary characterisation of the spatial immune and vascular environment in triple negative basal breast carcinomas using multiplex fluorescent immunohistochemistry.
    PLoS One. 2025;20:e0317331.
    >> Share

  116. ALDWOAH K, Louati H, Eljaneid N, Aljaaidi T, et al
    Fractional and stochastic modeling of breast cancer progression with real data validation.
    PLoS One. 2025;20:e0313676.
    >> Share

  117. WANG X, Leow QHM, Lee HK, Mok CY, et al
    Healthcare providers' (HCPs) perspectives in initiating discussion on mammogram screening, and their perceived barriers and enablers to screening in women-A qualitative study.
    PLoS One. 2025;20:e0311999.
    >> Share

  118. KAYA M, Abuaisha A, Suer I, Emiroglu S, et al
    Let-7b-5p sensitizes breast cancer cells to doxorubicin through Aurora Kinase B.
    PLoS One. 2025;20:e0307420.
    >> Share

  119. YU DY, Lee TY, Kim DW, Chang YW, et al
    Preliminary experience and learning curve of endoscopic nipple-areolar-complex sparing total mastectomy: A single-center retrospective study.
    PLoS One. 2025;20:e0311764.
    >> Share

  120. JENSEN MD, Hansen KM, Siersma V, Brodersen J, et al
    Mammography screening: Eliciting the voices of informed citizens.
    PLoS One. 2025;20:e0317263.
    >> Share

  121. GRASSI M, Tarantino B
    SEMdag: Fast learning of Directed Acyclic Graphs via node or layer ordering.
    PLoS One. 2025;20:e0317283.
    >> Share

  122. ALHAWARRI MB, Al-Thiabat MG, Dubey A, Tufail A, et al
    Targeting necroptosis in MCF-7 breast cancer cells: In Silico insights into 8,12-dimethoxysanguinarine from Eomecon Chionantha through molecular docking, dynamics, DFT, and MEP studies.
    PLoS One. 2025;20:e0313094.
    >> Share

  123. MALEKI F, Handali S, Rezaei M
    The role of mitochondrial dysfunction in the cytotoxic synergistic effect of gemcitabine and arsenic on breast cancer.
    PLoS One. 2025;20:e0312424.
    >> Share


  124. Correction: In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell lines.
    PLoS One. 2025;20:e0317835.
    >> Share

  125. ANOSOVA O, Head A, Collins B, Alexiou A, et al
    Estimating the burden of underdiagnosis within England: A modelling study of linked primary care data.
    PLoS One. 2025;20:e0313877.
    >> Share

  126. AYEBENG C, Okyere J, Okantey C, Addo IY, et al
    Multifaceted barriers associated with clinical breast examination in sub-Saharan Africa: A multilevel analytical approach.
    PLoS One. 2025;20:e0316800.
    >> Share

  127. HUANG S, Huang M, Long F, Wang F, et al
    Post-traumatic growth experience of breast cancer patients: A qualitative systematic review and meta-synthesis.
    PLoS One. 2025;20:e0316108.
    >> Share

  128. REAL-PEREZ M, Fernandez-Garcia JC, Gavala-Gonzalez J
    Effects of a 6-month rowing training program in breast cancer survivors.
    PLoS One. 2025;20:e0317118.
    >> Share

  129. HENRY NL, Kidwell KM, Kozar S, Snyder S, et al
    Self-acupressure for patients with breast cancer experiencing aromatase inhibitor-associated musculoskeletal symptoms: Protocol for the AcuAIM randomized pilot trial.
    PLoS One. 2025;20:e0311044.
    >> Share

  130. LIU X, Yang T, Yao J
    Impact of digital breast tomosynthesis on screening performance and interval cancer rates compared to digital mammography: A meta-analysis.
    PLoS One. 2025;20:e0315466.
    >> Share

  131. DEMEKE AD, Deribe B, Girma M, Gizaw M, et al
    Screening attendance of breast or cervical cancers and its associated factors among 30-49 year old women in Gedeo zone, South Ethiopia: Cross-sectional study.
    PLoS One. 2025;20:e0315891.
    >> Share

  132. UM S, Sopheab H
    Breast and cervical cancer screening among women at reproductive age in Cambodia: A secondary analysis of Cambodia Demographic and Health Survey 2022.
    PLoS One. 2025;20:e0295881.
    >> Share

  133. ELKAEED EB, Elkady H, Khattab AM, Yousef RG, et al
    Integrated in silico and in vitro exploration of the anti-VEGFR-2 activities of a semisynthetic xanthine alkaloid inhibiting breast cancer.
    PLoS One. 2025;20:e0316146.
    >> Share

  134. GAO Y, Liang G, Chang C, Pan F, et al
    Analysis of cervical and breast cancer screening behavior and its influencing factors among urban and rural women in Beijing.
    PLoS One. 2025;20:e0316898.
    >> Share

  135. LI B, Liu J, Zhang Y, Yang W, et al
    Comparative readability of information on different treatment options for breast cancer, based on WeChat public accounts.
    PLoS One. 2025;20:e0317032.
    >> Share

  136. LIU L, Meng Z, Yan J
    Efficacy of acupuncture in treating chemotherapy-related cognitive impairment in breast cancer patients: A systematic review and meta-analysis protocol.
    PLoS One. 2025;20:e0318984.
    >> Share

  137. LAI Y, Huang P
    Machine learning identifies the association between second primary malignancies and postoperative radiotherapy in young-onset breast cancer patients.
    PLoS One. 2025;20:e0316722.
    >> Share

  138. KITAGAWA T
    Hydrothermal treatment of yeast cell wall generates potent anti-proliferative agents targeting MCF7 breast cancer cells effectively even under culture conditions separated by a plastic wall.
    PLoS One. 2025;20:e0313379.
    >> Share

  139. NAFIE EHO, Pastori C, Acharya R, Kaviani R, et al
    Understanding the aliya pulsed electric field dose-response relationship: Implications for ablation size, thermal load, and immune response in an orthotopic murine breast cancer model.
    PLoS One. 2025;20:e0318440.
    >> Share

  140. OLSSON IM, Dykes C, Ryden L, Olsson-Moller U, et al
    Experiences of rehabilitation one year after breast cancer diagnosis-A focus group study from the ReScreen randomized controlled trial.
    PLoS One. 2025;20:e0315814.
    >> Share

  141. PARK P, Choi Y, Han N, Park YL, et al
    Leveraging natural language processing for efficient information extraction from breast cancer pathology reports: Single-institution study.
    PLoS One. 2025;20:e0318726.
    >> Share

  142. DONG J, Lei R, Ma F, Yu L, et al
    Machine learning-based prediction of distant metastasis risk in invasive ductal carcinoma of the breast.
    PLoS One. 2025;20:e0310410.
    >> Share

  143. KHAN MA, Khan ZA, Husain I, Upadhyay S, et al
    Effects of pressure on the survival and viability of cancer cells in vitro: An analytical study.
    PLoS One. 2025;20:e0311685.
    >> Share


  144. Retraction: A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells.
    PLoS One. 2025;20:e0319490.
    >> Share

  145. ALI MS
    Multilevel analysis of undergoing clinical breast examination and its associated factors among mothers of reproductive age in Kenya: Kenyan Demographic and Health Survey 2022.
    PLoS One. 2025;20:e0319183.
    >> Share


  146. Retraction: BMP9 inhibits proliferation and metastasis of HER2-positive SK-BR-3 breast cancer cells through ERK1/2 and PI3K/AKT pathways.
    PLoS One. 2025;20:e0320173.
    >> Share

  147. MILLER A, De May H, Rou DL, Agarwal JP, et al
    Understanding the early molecular changes associated with radiation therapy-A preliminary bulk RNA sequencing study.
    PLoS One. 2025;20:e0316443.
    >> Share

  148. STOFFEL ST, Natale C, von Wagner C
    The impact of temporal framing of breast cancer risk on perceptions of and motivations to engage with information about early diagnosis: Evidence from an online experiment.
    PLoS One. 2025;20:e0320245.
    >> Share


  149. Retraction: Tanshinone IIA inhibits HIF-1alpha and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway.
    PLoS One. 2025;20:e0321151.
    >> Share

  150. NI X, Wang W, Sun H, An R, et al
    A new marker for predicting sentinel lymph node metastasis in early (cT1-2N0) breast cancer: Tumor-infiltrating lymphocytes (TILs).
    PLoS One. 2025;20:e0320487.
    >> Share

  151. LE MN, Chen D, Smith KA, Tran DD, et al
    Microfluidic isolation and release of live disseminated breast tumor cells in bone marrow.
    PLoS One. 2025;20:e0319392.
    >> Share

  152. MALLARI MA, Singh A, Shubella J, Khaliq W, et al
    Cancer screening prevalence and preference among hospitalized women with and without diabetes mellitus.
    PLoS One. 2025;20:e0319681.
    >> Share

  153. RAHMANDOUST M, Abdolrahimi S
    Introducing carbon quantum dot-Capivasertib drug carrier complex for enhanced treatment of breast cancer.
    PLoS One. 2025;20:e0319206.
    >> Share

  154. CHEN J, He L, Shi Y, Jiao J, et al
    Effect of opioid-free anesthesia combined with pectoral nerve block on the quality of recovery in patients after mastectomy: A randomized, controlled trial.
    PLoS One. 2025;20:e0320592.
    >> Share

  155. EANES LA, Eldeeb M, Storholt D, Patel YM, et al
    Naringenin impairs mitochondrial function via ROS to induce apoptosis in tamoxifen resistant MCF-7 breast cancer cells.
    PLoS One. 2025;20:e0320020.
    >> Share

  156. JAVRUSHYAN H, Ginovyan M, Harutyunyan T, Gevorgyan S, et al
    Elucidating the impact of Hypericum alpestre extract and L-NAME on the PI3K/Akt signaling pathway in A549 lung adenocarcinoma and MDA-MB-231 triple-negative breast cancer cells.
    PLoS One. 2025;20:e0303736.
    >> Share

  157. CHEN P, Qiao D, Xiao L, Deng G, et al
    Cost-effectiveness analysis of toripalimab combined with nab-paclitaxel as a first-line treatment for advanced TNBC in the US.
    PLoS One. 2025;20:e0320727.
    >> Share

  158. ABUHAY HW, Alemu GG, Aweke MN, Alemu TG, et al
    Clinical breast cancer screening uptake and associated factors among reproductive age women in Kenya: further analysis of Kenyan Demographic and Health Survey 2022.
    PLoS One. 2025;20:e0320730.
    >> Share

  159. EL-TANANI M, Satyam SM, Rabbani SA, Obeidat RM, et al
    Decoding oncogenic secrets of regulator of chromosome condensation 1: A breakthrough mechanistic evidence from breast and lung cancer models.
    PLoS One. 2025;20:e0319748.
    >> Share

  160. SAGHAZADEH A
    Study of heterogeneity in immune responses to exposure in breast cancer: A protocol for a systematic review.
    PLoS One. 2025;20:e0320498.
    >> Share

  161. GODINA C, Khazaei S, Belting M, Vallon-Christersson J, et al
    Correction: High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome.
    PLoS One. 2025;20:e0322403.
    >> Share

  162. MAHAR B, Osman MB, Ahmad Fauzi FB
    Effectiveness of theory-based breast self-examination intervention for breast cancer prevention among female college teachers in Pakistan: A cluster randomized controlled trial study protocol.
    PLoS One. 2025;20:e0321634.
    >> Share

  163. SINGH A, Dwivedi RK, Singh VK, Sharma M, et al
    Modeling and simulation of an effectual triangular slotted UWB flexible antenna for breast cancer detection and healthcare monitoring.
    PLoS One. 2025;20:e0320806.
    >> Share

  164. ZHU G, Dong Y, Zhu R, Tan Y, et al
    Dynamic contrast-enhanced magnetic resonance imaging parameters combined with diffusion-weighted imaging for discriminating malignant lesions, molecular subtypes, and pathological grades in invasive ductal carcinoma patients.
    PLoS One. 2025;20:e0320240.
    >> Share

  165. KIVUYO N, Akoko L, Mutajwaha JOG, Haule C, et al
    Dismal pathological response to neoadjuvant chemotherapy in stage III breast cancer patients in Tanzania: A retrospective review.
    PLoS One. 2025;20:e0321187.
    >> Share

  166. BAIDOO TG, Rodrigo H
    Data-driven survival modeling for breast cancer prognostics: A comparative study with machine learning and traditional survival modeling methods.
    PLoS One. 2025;20:e0318167.
    >> Share

  167. ENEH S, Hartikainen JM, Heikkinen S, Sironen R, et al
    High expression of miR-7974 predicts poor prognosis and is associated with autophagy in estrogen receptor-positive breast cancer.
    PLoS One. 2025;20:e0322179.
    >> Share

  168. YE X, Xu T, Cao J, Li G, et al
    Knowledge, attitude, and practice toward genetic testing in breast cancer patients in China.
    PLoS One. 2025;20:e0322526.
    >> Share

  169. MIRZAEI Y, Huffel M, McCann S, Bannach-Brown A, et al
    Animal models in preclinical metastatic breast cancer immunotherapy research: A systematic review and meta-analysis of efficacy outcomes.
    PLoS One. 2025;20:e0322876.
    >> Share

  170. MOHAMMAD HUSSIN N, Nik Jaafar NR, Idris IB, Mohammed Nawi A, et al
    Evaluating the effects of e-health interventions on mental health outcomes in individuals with breast cancer: A systematic review.
    PLoS One. 2025;20:e0321495.
    >> Share

  171. RAMLI HAMID MT, Ab Mumin N, Abdul Hamid S, Mohd Ariffin N, et al
    Comparative analysis of diagnostic performance in mammography: A reader study on the impact of AI assistance.
    PLoS One. 2025;20:e0322925.
    >> Share

  172. YANG S, Cheng M, Zhang S, Wang H, et al
    DNMT3A facilitates breast cancer progression via regulating ADAMTS8 mediated EGFR-MEK-ERK activation.
    PLoS One. 2025;20:e0321889.
    >> Share

  173. PRAJOKO YW, Heriyanto DS, Dirja BT, Susanto S, et al
    High frequency of the PIK3CA H1047L mutation in Indonesian breast cancer across molecular subtypes.
    PLoS One. 2025;20:e0322154.
    >> Share


  174. Retraction: Response of breast cancer cells and cancer stem cells to metformin and hyperthermia alone or combined.
    PLoS One. 2025;20:e0323982.
    >> Share

  175. DOUGLAS CM, Newell M, Goruk S, Courneya KS, et al
    Exploratory outcomes of the DHA WIN randomized controlled trial: Supplementing women with docosahexaenoic acid did not reduce the impact of neoadjuvant breast cancer chemotherapy on quality of life or exercise behaviour.
    PLoS One. 2025;20:e0322178.
    >> Share

  176. RABBANI B, Tanu SG, Ramanto KN, Audrienna J, et al
    A combined risk model shows viability for personalized breast cancer risk assessment in the Indonesian population: A case/control study.
    PLoS One. 2025;20:e0321545.
    >> Share

  177. KHOSROWZADEH N, Saini AS, Samimi K, Chambers K, et al
    Disparities in physician compensation for breast and prostate cancer operations.
    PLoS One. 2025;20:e0323892.
    >> Share

  178. WU WP, Lin J, Huang YL, Chen ST, et al
    Magnetic resonance imaging characteristics and survival outcomes of metaplastic breast carcinoma.
    PLoS One. 2025;20:e0323541.
    >> Share

  179. AZMI MB, Yu H, Sohail A, Asif U, et al
    In silico analysis to explore the therapeutic potential of propolis-derived small molecules as matriptase inhibitors to suppress breast cancer growth and metastasis.
    PLoS One. 2025;20:e0321687.
    >> Share

  180. PRADO-CELIS LP, Zamora-Cardenas R, Alamilla J, Sanchez-Pastor EA, et al
    Nucleolar sequestration of cannabinoid type-2 receptors in triple-negative breast cancer cells.
    PLoS One. 2025;20:e0323554.
    >> Share

  181. KINTEH B, Jitteh F, Badjie M, Barrow A, et al
    Exploring breast cancer awareness and screening practices amongst rural women in The Gambia: Community-based cross-sectional study.
    PLoS One. 2025;20:e0307785.
    >> Share


  182. Correction: Retraction: Tanshinone IIA Inhibits HIF-1alpha and VEGF Expression in Breast Cancer Cells via mTOR/p70S6K/RPS6/4E-BP1 Signaling Pathway.
    PLoS One. 2025;20:e0324274.
    >> Share

  183. CHEN C, Gao D, Yue H, Wang H, et al
    Predicting breast cancer prognosis based on a novel pathomics model through CHEK1 expression analysis using machine learning algorithms.
    PLoS One. 2025;20:e0321717.
    >> Share

  184. DANISH F
    A design-based framework for optimal stratification using super-population models with application on real data set of breast cancer.
    PLoS One. 2025;20:e0323619.
    >> Share

  185. DINKEL Z, Baker A, Akins A, King KL, et al
    Collagen architecture in triple negative breast cancer.
    PLoS One. 2025;20:e0324655.
    >> Share

  186. PUN Z, Xue Q, Zhang Y
    Enhancing ERalpha-targeted compound efficacy in breast cancer threapy with ExplainableAI and GeneticAlgorithm.
    PLoS One. 2025;20:e0319673.
    >> Share

  187. FANG W, Tang S, Yan D, Dai X, et al
    Breast cancer pathology image recognition based on convolutional neural network.
    PLoS One. 2025;20:e0311728.
    >> Share

  188. KHODADADI H, Nazem S
    Improving cancer detection through computer-aided diagnosis: A comprehensive analysis of nonlinear and texture features in breast thermograms.
    PLoS One. 2025;20:e0322934.
    >> Share

  189. ABUBAKARI AK, Gross J, Adusei-Poku E
    Factors influencing clinical breast cancer screening: A cross-sectional study among Islamic women in Kumasi Metropolis of Ghana.
    PLoS One. 2025;20:e0320726.
    >> Share

  190. RIOKI JN, Mweu M, Rogena E, Songok EM, et al
    Factors associated with breast lesions among women attending select teaching and referral health facilities in Kenya: A cross-sectional study.
    PLoS One. 2025;20:e0309182.
    >> Share

  191. MARGULIES BS, Likhitpanichkul M, Tripathy D
    Reshaping the landscape of locoregional treatments for breast cancer liver metastases: A novel, intratumoral, p21-targeted percutaneous therapy increases survival in BALB/c mice inoculated with 4T1 triple negative breast cancer cells in the liver.
    PLoS One. 2025;20:e0323621.
    >> Share

  192. WELLER SC, Pappadis MR, Krishnan S, Stearnes MR, et al
    Understanding motivations of older women to continue or discontinue breast cancer screening.
    PLoS One. 2025;20:e0319141.
    >> Share

  193. ISSA E, Lahoud R, Abi-Gerges A, Salameh P, et al
    Breast cancer screening practices during a multifaceted crisis: Data from Lebanon.
    PLoS One. 2025;20:e0325604.
    >> Share

  194. HOU PH, Chang GR, Chao YT, Chang YT, et al
    Aripiprazole use and lowering the risk of breast cancer in patient with schizophrenia in a national cohort study.
    PLoS One. 2025;20:e0324257.
    >> Share

  195. LOGANATHAN T, Doss C GP
    Gut microbiota and its influence on the Gut-Brain axis in comparison with chemotherapy patients and cancer-free control data in Breast cancer-A computational perspective.
    PLoS One. 2025;20:e0324742.
    >> Share

  196. WANG T, Zang B, Kong C, Li Y, et al
    Intelligent and precise auxiliary diagnosis of breast tumors using deep learning and radiomics.
    PLoS One. 2025;20:e0320732.
    >> Share

  197. POPIC D, Marinovich ML, Houssami N, Hall J, et al
    How should artificial intelligence be used in breast screening? Women's reasoning about workflow options.
    PLoS One. 2025;20:e0323528.
    >> Share

  198. GROSSE C, Noack P, Grosse A, Schwarz HK, et al
    Prognostic impact of HER2-low expression in triple-negative breast cancer of high-grade special histological type and no special type.
    PLoS One. 2025;20:e0325715.
    >> Share

  199. KIM A, Yi C, Ji M, Hwang UJ, et al
    Pectoralis minor length index at 1 month postoperative can predict homolateral neuropathic pain 4 months after mastectomy with lymph node resection.
    PLoS One. 2025;20:e0326119.
    >> Share

  200. FATIMA A, Khan MU, Ibrahim S, Khurram I, et al
    Multiscale computational evaluation of Vitex trifolia phytochemicals as VEGFR2 inhibitors for targeted breast cancer therapy.
    PLoS One. 2025;20:e0325255.
    >> Share

  201. ARAFAT HM, Al-Astani TAD, Shafii N, Muhamad R, et al
    Impact of IGFBP-3 A-202C genetic variant on breast cancer susceptibility and serum biomarkers (IGFBP-3 and IGF-1) in Palestinian women.
    PLoS One. 2025;20:e0325289.
    >> Share

  202. SHAON MA, Ansari F, Mahmud Z, Tamanna S, et al
    Aldo-keto reductase family 1 member C3 (AKR1C3) gene polymorphism (rs12529) is associated with breast cancer in Bangladeshi population: A case-control study and computational investigation.
    PLoS One. 2025;20:e0318079.
    >> Share

  203. MATUSIN SNI, Mumin N, Zainal Abidin H, Mohd Jaya FN, et al
    Prevalence and spectrum of germline BRCA1 and BRCA2 mutations in multiethnic cohort of breast cancer patients in Brunei Darussalam.
    PLoS One. 2025;20:e0312635.
    >> Share

  204. AHMED KA, Humaira I, Khan AR, Hasan MS, et al
    Advancing breast cancer prediction: Comparative analysis of ML models and deep learning-based multi-model ensembles on original and synthetic datasets.
    PLoS One. 2025;20:e0326221.
    >> Share

  205. FAN YC, Lin SC, Lai PJ, Lai PC, et al
    A psychiatric medication, clozapine, induces autophagy and apoptosis in breast cancer cells through reactive oxygen species.
    PLoS One. 2025;20:e0326224.
    >> Share


  206. Retraction: Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: Disconnect between activity and growth inhibition.
    PLoS One. 2025;20:e0326621.
    >> Share

  207. LARBI A, Nyarko E, Iddi S
    Evaluation of optimal strategies for breast cancer screening in Ghana: A simulation study based on a continuous tumor growth model.
    PLoS One. 2025;20:e0323485.
    >> Share

  208. HUTCHISON RE, Smith S, Caudell C, Biddle S, et al
    Effects of chemotherapy on skeletal muscle mitochondrial oxidative capacity using near-infrared spectroscopy (NIRS): Protocol paper for an observational mixed model repeated measures design in patients with breast and gynecological cancer.
    PLoS One. 2025;20:e0315351.
    >> Share

  209. UNLU YAZICI M, Marron JS, Bakir-Gungor B, Zou F, et al
    3Mont: A multi-omics integrative tool for breast cancer subtype stratification.
    PLoS One. 2025;20:e0326154.
    >> Share

  210. RUJIMONGKON K, Adchariyasakulchai P, Meeprasertskul P, Ketchart W, et al
    Ivermectin inhibits epithelial-to-mesenchymal transition via Wnt signaling in endocrine-resistant breast cancer cells.
    PLoS One. 2025;20:e0326742.
    >> Share

  211. MOFFETT L, Barnett AJ, Donnelly J, Schwartz FR, et al
    Multi-site validation of an interpretable model to analyze breast masses.
    PLoS One. 2025;20:e0320091.
    >> Share

  212. YING J, Cattell R, Huang C
    Cross-field strength and multi-vendor reliability of MagDensity for MRI-based quantitative breast density analysis.
    PLoS One. 2025;20:e0316076.
    >> Share

  213. BROWNSON-SMITH R, Carr J, Fox KT, Orange ST, et al
    The test-retest reliability of the H-Reflex and swaymeter in women aged 30-65 years.
    PLoS One. 2025;20:e0314437.
    >> Share

  214. NAMBA-BANDO MDMY, Contreras-Yanez I, Tenorio-Torres JA, Pascual-Ramos V, et al
    Futility in healthcare among Mexican female patients with breast cancer in advanced stage: The patient perspective.
    PLoS One. 2025;20:e0326332.
    >> Share

  215. ALSHAREEDA AT, Albarakati N, Alshawakir Y, Alghuwainem A, et al
    Improving the robustness and efficiency of cell sheet protocol for breast cancer induction in animal model: A Geltrex plus Gelatin approach.
    PLoS One. 2025;20:e0326456.
    >> Share

  216. WAKS-SERRA MV, Vera DA, Carbone NA, Garcia HA, et al
    Solid breast tumors phantom emulating oxy and deoxyhemoglobin concentrations for near infrared imaging.
    PLoS One. 2025;20:e0325768.
    >> Share

  217. JAHAN R, Bhuiyan AKMMR, Alam A, Chowdhury MK, et al
    Outcomes of complex decongestive therapy in managing upper limb lymphedema in female breast cancer patients at a palliative care unit of a tertiary care hospital in Bangladesh.
    PLoS One. 2025;20:e0326040.
    >> Share

  218. NDJENGUE BENGONE BC, Toniolo J, Filankembo Kava AC, Ngoungou EB, et al
    Psychological repercussions of breast or uterine cervical cancer disclosure to women in Gabon.
    PLoS One. 2025;20:e0326378.
    >> Share

  219. MSENGA U, Ambikile JS, Buluba SE
    Prevalence of anxiety and depression symptoms and associated factors among women diagnosed with breast cancer: A cross-sectional study at Ocean Road Cancer Institute in Dar es Salaam-Tanzania.
    PLoS One. 2025;20:e0326749.
    >> Share


  220. Expression of Concern: Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells.
    PLoS One. 2025;20:e0327518.
    >> Share

  221. ZAKI RM, Aldosari BN, Alkharashi LA, Alsalhi A, et al
    Fabrication and appraisal of axitinib loaded PEGylated spanlastics against MCF- 7 and OV- 2774 cell lines using molecular docking methods and in-vitro study.
    PLoS One. 2025;20:e0325055.
    >> Share

  222. DWAIRY M, Yehya A, Mohammad FM, Alzoubi H, et al
    Losartan as a mechanotherapeutic adjuvant: Remodeling the breast tumor microenvironment to improve treatment efficacy.
    PLoS One. 2025;20:e0328196.
    >> Share

  223. AHMED SF, Hossain MS, Mondal A, Shahariar M, et al
    In silico identification of promising PD-L1 inhibitors from selected indian medicinal plants for treatment of triple negative breast cancer.
    PLoS One. 2025;20:e0327475.
    >> Share

  224. SCERRI J, Agius J, Galea M
    Emergence of a new me: Experiences of women diagnosed with HER2-positive breast cancer.
    PLoS One. 2025;20:e0325080.
    >> Share

  225. ZAKI RM, Aldosari BN, Alkharashi LA, Alsalhi A, et al
    Fabrication and appraisal of targeted axitinib loaded bilosomes for the enhanced breast and ovarian anticancer activity.
    PLoS One. 2025;20:e0325511.
    >> Share

  226. KLDIASHVILI E, Abiatari I, Kekelia E, Iordanishvili S, et al
    SOX2, PIWI proteins, and MALAT1 - plasma-based emerging biomarkers for cancer detection and monitoring.
    PLoS One. 2025;20:e0328557.
    >> Share

  227. VUKEA N, Oderinlo O, Tukulula M, Khanye SD, et al
    Ferrocene thiazolidine-2,4-dione derivatives cause DNA damage and interfere with DNA repair in triple-negative breast cancer cells.
    PLoS One. 2025;20:e0328155.
    >> Share

  228. HOIBO M, Pedersen A, Dale VG, Berget SM, et al
    Immunohistochemistry guided segmentation of benign epithelial cells, in situ lesions, and invasive epithelial cells in breast cancer slides.
    PLoS One. 2025;20:e0328033.
    >> Share

  229. PEREIRA SAP, Vesin J, Chambon M, Turcatti G, et al
    Identification of glutathione transferase (GST P1) inhibitors via a high-throughput screening assay and implications as alternative treatment options for breast cancers.
    PLoS One. 2025;20:e0319904.
    >> Share

  230. ROSTAMI Z, Mukund K, Masnadi-Shirazi M, Subramaniam S, et al
    An autoencoder learning method for predicting breast cancer subtypes.
    PLoS One. 2025;20:e0327773.
    >> Share

  231. KRETZMANN HG, Adeniyi OV
    Clinicopathological and molecular subtypes of breast cancer in the Eastern Cape, South Africa: A two-year retrospective study.
    PLoS One. 2025;20:e0325387.
    >> Share

  232. PARKER G, Hogarth S, Fishman J, Miller FA, et al
    Prognosis, treatment decision-making and value: A qualitative exploration of the emerging role of breast cancer prognostic assays.
    PLoS One. 2025;20:e0322509.
    >> Share

  233. MOHD ZAIN AH, Mohd Isa SA, Che Jalil NA, Mohd Hairon S, et al
    Modification of the nuclear pleomorphism score in the Modified Bloom-Richardson grading for invasive breast cancer.
    PLoS One. 2025;20:e0327860.
    >> Share

  234. BOGALE M, Mengstie TA, Tadesse E, Dejenie TA, et al
    Association of FGF Receptor-2rs2981578 SNP with breast cancer in women at the University of Gondar Comprehensive Specialized Hospital, Ethiopia.
    PLoS One. 2025;20:e0327034.
    >> Share

  235. WATABE S, Watanabe T, Yada S, Aramaki E, et al
    Correction: Exploring a method for extracting concerns of multiple breast cancer patients in the domain of patient narratives using BERT and its optimization by domain adaptation using masked language modeling.
    PLoS One. 2025;20:e0329664.
    >> Share

  236. LEE J, Foroughi M, Kung V, Ali R, et al
    Molecular and morphological alterations in breast tissue of transgender patients undergoing dihydrotestosterone therapy.
    PLoS One. 2025;20:e0325034.
    >> Share

  237. LIU X, Wu H, Zhang S, Zhu Z, et al
    Higher red cell distribution width (RDW) is associated with increased all-cause and cardiovascular mortality in patients with breast cancer: A retrospective analysis of NHANES data (1999-2018).
    PLoS One. 2025;20:e0328680.
    >> Share

  238. LI X, Liu Y, Wang Z, Bu X, et al
    Response Gene to Complement 32 promotes cell proliferation and tamoxifen resistance in breast cancer via elevated FoxM1 expression.
    PLoS One. 2025;20:e0328698.
    >> Share

  239. DANIELS J, Kyei KA, Walubo R, Nyantakyi AY, et al
    Prevalence and clinicopathological characteristics of breast cancer patients with brain metastases in Ghana: A single-center cross-sectional study.
    PLoS One. 2025;20:e0329308.
    >> Share

  240. HELU A, Samawi H
    Assessing uncertainty: A study of entropy measures for Burr XII distribution under progressive Type-II censoring.
    PLoS One. 2025;20:e0329086.
    >> Share

  241. AGIDE FD, Garmaroudi G, Sadeghi R, Shakibazadeh E, et al
    Designing and evaluation of the effect of community-based intervention on breast self-examination among reproductive-aged women in Ethiopia: A Cluster Randomized Controlled Trial.
    PLoS One. 2025;20:e0329839.
    >> Share

  242. LU X, Wei C, Li C, Liu J, et al
    Do skin bacteriostatic agents reduce acute radiodermatitis in breast cancer patients? A prospective interventional study.
    PLoS One. 2025;20:e0328536.
    >> Share

  243. TSAI MH, Vo JB, Moore JX, Ramin C, et al
    Mediating effects of mental and physical health on the association between chronic disease conditions and colorectal cancer screening utilization among breast cancer survivors.
    PLoS One. 2025;20:e0328353.
    >> Share

  244. YANG C, Liu Y, Gai L, Zhang Z, et al
    Artesunate regulates malignant progression of breast cancer cells via lncRNA TUG1/miR-145-5p/HOXA5 axis.
    PLoS One. 2025;20:e0329490.
    >> Share

  245. VEZZANI F, Cabieses B, Obach A, Torrealba S, et al
    Unmet supportive care needs of young women with breast cancer in Chile during follow-up stage after treatment: A qualitative study.
    PLoS One. 2025;20:e0330166.
    >> Share

  246. KHATRI RB, Endalamaw A, Darssan D, Assefa Y, et al
    A scoping review of the levels, implementation strategies, enablers, and barriers to cervical, breast, and colorectal cancer screening among migrant populations in selected English-speaking high-income countries.
    PLoS One. 2025;20:e0329854.
    >> Share

  247. SALAR-ANDREU C, Montero-Navarro S, Lozano-Rubio A, Del Rio-Medina S, et al
    Effectiveness of radiofrequency and exercise-based rehabilitation on symptoms associated with pelvic floor dysfunction in breast cancer patients: A study protocol.
    PLoS One. 2025;20:e0330156.
    >> Share

  248. ALOMAIRY NA
    The impact of breast cancer awareness campaigns on the knowledge, attitudes, and practices of breast cancer screening among Saudi female employees.
    PLoS One. 2025;20:e0331765.
    >> Share

  249. KONAKA Y, Ueda T, Inamori R, Sato J, et al
    Breast cancer classification based on the integration of diagnostic algorithms for calcifications and masses using a mixture of experts.
    PLoS One. 2025;20:e0331017.
    >> Share

  250. XIONG J, Zhang D, Yuan Y, Quan C, et al
    Association between Systemic Immune-Inflammation Index and female breast cancer based on NHANES data (2001-2018): A cross-sectional study.
    PLoS One. 2025;20:e0330571.
    >> Share

  251. JASSIM GHRABAT MJ, Ghaib AA, Al-Hossenat A, Abduljabbar ZA, et al
    Effective SMOTE boost with deep learning for IDC identification in whole-slide images.
    PLoS One. 2025;20:e0329078.
    >> Share

  252. LIAO Y, Mohd Hairon S, Majdi Yaacob N, Alina Tengku Ismail T, et al
    Psychometric validation of a culturally adapted health belief model scale for breast cancer screening in Chinese women.
    PLoS One. 2025;20:e0331279.
    >> Share

  253. ARIK A, Cairns AJG, Streftaris G
    Cancer disparities: Projection, COVID-19, and scenario-based diagnosis delay impact.
    PLoS One. 2025;20:e0330752.
    >> Share

  254. RAHIMZADEH S, Bentham J, Burczynska B, Farzadfar F, et al
    Spatiotemporal disparity of breast cancer incidence in Iranian female populations at the district level from 2000 to 2021: Bayesian disease mapping.
    PLoS One. 2025;20:e0330017.
    >> Share

  255. JIA C, Yang F
    Integrative network toxicology and molecular docking reveal 4-Nonylphenol's multifaceted mechanisms in breast cancer pathogenesis.
    PLoS One. 2025;20:e0331944.
    >> Share

  256. BRAUN T, Huesmann S, Pfister K, Friedl TWP, et al
    The SURVIVE study (NCT05658172): Bringing breast cancer aftercare to the 21stcentury: Study protocol of a Phase III clinical trial comparing liquid biopsy guided vs. Standard of care surveillance for intermediate to high-risk breast cancer survivors.
    PLoS One. 2025;20:e0331203.
    >> Share

  257. YUN H, Noh S, Cho H, Ko EY, et al
    AI-Driven quality assurance in mammography: Enhancing quality control efficiency through automated phantom image evaluation in South Korea.
    PLoS One. 2025;20:e0330091.
    >> Share

  258. JAFRIN S, Aziz MA, Barek MA, Reza MS, et al
    Association of missense variant DCLRE1B rs3761936 with breast and cervical cancer risk-A case-control study.
    PLoS One. 2025;20:e0331492.
    >> Share

  259. RAMZAN R, Bukhari SA, Rasul A
    Identification of silibinin and isotretinoin as potent up-regulators of sFRP4 (Wnt antagonist): In silico prediction and in vitro validation in breast cancer.
    PLoS One. 2025;20:e0331735.
    >> Share

  260. PRADO SOUSA AC, Duran-Prado M, Villar M, Gonzalez-Garcia A, et al
    Tick saliva protein fraction inhibits breast cancer by decreasing cell viability and promoting apoptosis in vitro.
    PLoS One. 2025;20:e0331779.
    >> Share

  261. HUNDLEY WW, O'Connell NS, Kirkman DL, Olson KC, et al
    Statins to reduce renal sinus fat among breast cancer patients undergoing anthracycline-based chemotherapy: A substudy of PREVENT-WF-98213.
    PLoS One. 2025;20:e0318017.
    >> Share

  262. ABDEL-HAMID L, Yogarajah P, Tealab SHA
    Lightweight deep models based on domain adaptation and network pruning for breast cancer HER2 scoring: IHC vs. H&E histopathological images.
    PLoS One. 2025;20:e0332362.
    >> Share

  263. HERNANDEZ N, Pakarinen T, Salminen A, Castro SL, et al
    A systematic approach to study the effects of acquisition parameters and biological factors on computerized mammography analysis using ex vivo human tissue: A protocol description.
    PLoS One. 2025;20:e0321658.
    >> Share

  264. TUNA BG, Keles NA, Cicekdal MB, Dogan S, et al
    Distinct transcriptomic effects of intermittent and chronic caloric restriction in mammary fat pad of a breast cancer mouse model.
    PLoS One. 2025;20:e0331898.
    >> Share

  265. SOETOMO SA, Sharp MF, Crismani W
    Differential PARP inhibitor responses in BRCA1-deficient and resistant cells in competitive co-culture.
    PLoS One. 2025;20:e0332860.
    >> Share

  266. GUZMAN-LORITE M, Munoz-Moreno L, Marina ML, Carmena MJ, et al
    In vitro and in vivo approaches demonstrating the antiproliferative activity of pomegranate seed proteins and peptides on breast cancer.
    PLoS One. 2025;20:e0330895.
    >> Share

  267. ZIEGLER RODRIGUEZ G, De La Cruz Ku G, Hickey A, Roberts S, et al
    Special histological subtypes of breast cancer in a Hispanic Latino population.
    PLoS One. 2025;20:e0333139.
    >> Share

  268. ZHANG F, Zhou C, Yang Y, Li J, et al
    Clinicopathological and prognostic exploratory study of primary metaplastic squamous cell carcinoma of the breast.
    PLoS One. 2025;20:e0333347.
    >> Share

  269. MADARIAGA B, Mondschein S, Torres S
    Inequities in breast cancer outcomes in Chile: An analysis of case fatality ratios and survival rates (2007-2018).
    PLoS One. 2025;20:e0325252.
    >> Share

  270. MITCHELL HJ, McShane CM, Hawkins ST, Lohfeld L, et al
    Impact of COVID-19 on breast cancer patients and services in a UK region: Protocol for a mixed methods study.
    PLoS One. 2025;20:e0333288.
    >> Share

  271. ANTONUCCI A, Lucas AR, Costa J, Norton S, et al
    Physical activity is associated with exercise capacity among patients undergoing chemotherapy: A pilot randomized controlled trial.
    PLoS One. 2025;20:e0329774.
    >> Share

  272. BENMUSSA C, Sanfeliu E, Martinez-Romero A, Gonzalez-Farre B, et al
    Latent representation of H&E images retains biological information in a breast cancer cohort.
    PLoS One. 2025;20:e0329221.
    >> Share

  273. WEN M, Zeng Y, Zhang P, Yang J, et al
    Investigation of anxiety levels and associated factor analysis in breast cancer patients undergoing chemotherapy with implanted venous access ports during the stable phase of disease.
    PLoS One. 2025;20:e0332826.
    >> Share

  274. SAKAI Y, Kobayashi A, Akata M, Tojo K, et al
    Effects of anesthetic management on persistent pain after breast cancer surgery.
    PLoS One. 2025;20:e0333878.
    >> Share

  275. ADISU MA, Habtie TE, Kitaw TA, Gessesse AD, et al
    The rising burden of female cancer in Ethiopia (2000-2021) and projections to 2040: Insights from the global burden of disease study.
    PLoS One. 2025;20:e0333787.
    >> Share

  276. TANG P, Zhang Q, Meng LC, Chen M, et al
    Predicting the axillary lymph node tumor burden in breast cancer patients using ultrasonic radiomics nomogram model.
    PLoS One. 2025;20:e0333172.
    >> Share

  277. RAMADAN MM, Alkhatabi HA, Aboalola D, Alaa S, et al
    Burden, and trends of breast cancer along with attributable risk factors in Gulf Cooperation Council countries from 1990 to 2019 and its projections.
    PLoS One. 2025;20:e0331198.
    >> Share

  278. LESER C, Kabashi F, Dorffner G, Zaric O, et al
    Exploring the role of routine brain imaging in detecting asymptomatic brain metastases in first diagnosed HER2-positive breast cancer.
    PLoS One. 2025;20:e0334610.
    >> Share

  279. GUEVARA-NIETO HM, Orozco-Castano CA, Parra-Medina R, Poveda-Garavito JN, et al
    Molecular determinants of neoadjuvant chemotherapy resistance in breast cancer: An analysis of gene expression and tumor microenvironment.
    PLoS One. 2025;20:e0334335.
    >> Share

  280. ZHANG Z, Li Y, Huang H, Wei T, et al
    Disparities and trends of the incidence and mortality of female-specific cancers in the United States.
    PLoS One. 2025;20:e0334128.
    >> Share

  281. ZHANG XR, Yuan SS, Hu JJ, Chen QQ, et al
    An exploratory study on predicting HER2-positive expression status of breast cancer using ultrasound radiomics combined with machine learning models.
    PLoS One. 2025;20:e0334909.
    >> Share

  282. CHIODI A, Pelucchi P, Mosca E
    Analysis of intracellular and intercellular crosstalk from omics data.
    PLoS One. 2025;20:e0334981.
    >> Share

  283. FONSECA-BENITEZ AV, Diaz-Baez D, Guevara-Pulido J, Rondon-Lagos M, et al
    Prognostic value of FOXA1 in estrogen receptor-negative breast cancer: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0332516.
    >> Share

  284. SAH AK, Prajapati R, Pathak N, Panta S, et al
    Assessment of drug-related problems among breast cancer patients in a cancer specialty center in Nepal.
    PLoS One. 2025;20:e0334703.
    >> Share

  285. SRIKUMMOON P, Traisathit P, Onchan W, Ditsatham C, et al
    The recurrence and mortality risk in Luminal A breast cancer patients who lived in high pollution area.
    PLoS One. 2025;20:e0335140.
    >> Share

  286. LIU J, Liu J, Wang M, Wang X, et al
    Opioid-sparing anesthesia versus opioid-free anesthesia for postoperative recovery quality in breast cancer surgery patients: A systematic review and Bayesian network meta-analysis.
    PLoS One. 2025;20:e0334614.
    >> Share

  287. AHMADI M, Nemat A, Sakhi R, Ahmadi A, et al
    Knowledge and practice of breast self-examination and associated factors among women with breast cancer in Kabul, Afghanistan.
    PLoS One. 2025;20:e0335460.
    >> Share

  288. HASAN MS, Ni S, Kamal FB, Blossey MF, et al
    Sequestration and suppressed synthesis of oncogenic HMGA1 using engineered adenoviruses decreases human pancreatic and breast cancer cell characteristics.
    PLoS One. 2025;20:e0335934.
    >> Share

  289. ZHAO M, Ma Z, Parris AB, Yang X, et al
    LSR overexpression induces chemoresistance in triple negative breast cancer cells through MDR1 upregulation and apoptosis attenuation.
    PLoS One. 2025;20:e0336124.
    >> Share

  290. BOUSQUET M, Lange M, Lequesne J, Durand-Zaleski I, et al
    Remotely supervised online cognitive training to reduce cognitive difficulties following chemotherapy in patients treated for localized breast cancer: Protocol of the Cog-Stim2 multicenter randomized controlled trial.
    PLoS One. 2025;20:e0335124.
    >> Share

  291. ABEBE M, Asgedom YS, Gebrekidan AY, Tebeje TM, et al
    Factors influencing breast cancer screening among reproductive age women in Lesotho: Analysis of the 2023-24 demographic and health survey using the Andersen Behavioral Model.
    PLoS One. 2025;20:e0336983.
    >> Share

  292. SMOTHERMAN C, Sprague BL, Braithwaite D, Yaghjyan L, et al
    Greenness and its interaction with air pollution in relation to postmenopausal breast cancer risk in UK Biobank.
    PLoS One. 2025;20:e0334744.
    >> Share

  293. PFISTER K, Friedl TWP, Hartkopf A, Mergel F, et al
    Study Protocol of SURVIVE HERoes (NCT06643585): Trastuzumab Deruxtecan for molecular relapse in HER2+/ Low early breast cancer with ctDNA positivity after primary therapy.
    PLoS One. 2025;20:e0322156.
    >> Share

  294. ZHANG S, Zhang R, Xia Y, Cao D, et al
    Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events.
    PLoS One. 2025;20:e0336767.
    >> Share

  295. SEKYERE AO, Iddrisu M, Mumuni HI, Konlan KD, et al
    Supportive care needs and challenges experienced by women diagnosed with breast cancer in Kumasi, Ghana: A qualitative exploratory study.
    PLoS One. 2025;20:e0336860.
    >> Share

  296. NGUYEN TTT, Pham PTV, Nguyen VAT, Nguyen TTT, et al
    Taxonomic characterization and cytotoxic potential of Vietnamese Ganoderma ellipsoideum against human breast cancer MCF-7 cells.
    PLoS One. 2025;20:e0336024.
    >> Share

  297. STUTZIN DONOSO F, Archer S, Walter FM, Morris S, et al
    CanRisk-GP protocol: A feasibility study of incorporating proactive multifactorial breast cancer risk assessment into general practice.
    PLoS One. 2025;20:e0336902.
    >> Share

  298. AL DHAHERI Y, Attoub S, Ramadan G, Arafat K, et al
    Correction: Carnosol Induces ROS-Mediated Beclin1-Independent Autophagy and Apoptosis in Triple Negative Breast Cancer.
    PLoS One. 2025;20:e0337572.
    >> Share

  299. VAN CAPPELLEN-VAN MALDEGEM SJM, Kruif A, Seidell JC, van de Poll-Franse LV, et al
    Determinants and timing of lifestyle changes in postmenopausal breast cancer survivors: A longitudinal qualitative study.
    PLoS One. 2025;20:e0337089.
    >> Share

  300. LI W, Wang X, Yu Q, Zhou W, et al
    Symptom network analysis in breast cancer patients: A scoping review.
    PLoS One. 2025;20:e0336793.
    >> Share

  301. HOSSIN AY, Rahman MN, Hasan MM, Karim A, et al
    Evaluation of dihydropyranocoumarins as potent inhibitors against triple-negative breast cancer: An integrated of in silico, quantum & molecular modeling approaches.
    PLoS One. 2025;20:e0334939.
    >> Share

  302. ALSALAH JH
    Incidental extramammary findings on breast magnetic resonance imaging: Prevalence and recommended diagnostic follow-up.
    PLoS One. 2025;20:e0319373.
    >> Share

  303. ZHAO Y, Lan S, Li X, Deng Y, et al
    Investigating the mechanism of oridonin against triple-negative breast cancer based on network pharmacology and molecular docking.
    PLoS One. 2025;20:e0332697.
    >> Share

  304. LIANG B, Duan Z, Long S, Zhou P, et al
    Infiltration of CXCL9+ macrophages confers a favorable prognosis in breast cancer: Insights from an integrated single-cell RNA and bulk RNA sequencing study.
    PLoS One. 2025;20:e0337175.
    >> Share

  305. ANBARI A, Massey Z, Adediran A, Wang N, et al
    "This needs to be told to everyone": Content analysis of written immediate responses from an online experiment examining health warning messages about alcohol consumption and breast cancer risk.
    PLoS One. 2025;20:e0338687.
    >> Share

  306. NIZAM AM
    Minimum Displacement in Existing Moment (MDEM)- A new supervised learning algorithm by incrementally constructing the moments of the underlying classes.
    PLoS One. 2025;20:e0336933.
    >> Share

  307. HAQ BU, Sofi S, Qayoom H, Jan N, et al
    Unravelling the therapeutic potential of dual TGFbeta-1 and CXCR4 inhibition in breast cancer using computational strategies.
    PLoS One. 2025;20:e0323665.
    >> Share

  308. GIVI T, Mohajerani F, Tehrankhah ZM, Karimi Taheri M, et al
    Nano-curcumin enhances the sensitivity of tamoxifen-resistant breast cancer cells via the Cyclin D1-DILA1 axis and the PI3K/AKT/mTOR pathway downregulation.
    PLoS One. 2025;20:e0335165.
    >> Share

  309. LIM YC, Lee YJ, Ha IH, Lee YS, et al
    Risk of cardiovascular disease and death in patients with breast cancer receiving anthracycline-based therapy: A retrospective cohort study.
    PLoS One. 2025;20:e0335083.
    >> Share

  310. ALMUTAIRI MH, Alrubie TM
    Contrasting effects of DNA demethylation on cancer-germline gene expression in breast cancer and leukemia cells.
    PLoS One. 2025;20:e0339460.
    >> Share


  311. Retraction: Investigating the relationship between insulin use and all-cause mortality, breast cancer mortality, and recurrence risk in diabetic patients with breast cancer: A comprehensive systematic review and meta-analysis.
    PLoS One. 2025;20:e0339149.
    >> Share


  312. Expression of Concern: Utilization of complementary and alternative medicine (CAM) by women with breast cancer or gynecological cancer.
    PLoS One. 2025;20:e0339083.
    >> Share

  313. BINTABARA D, Kamata CC, Mohamedi R, Basinda N, et al
    Spatial autocorrelation and determinants of low uptake of breast cancer screening among women of reproductive age: A mixed-effect multilevel analysis of Tanzanian population-based survey.
    PLoS One. 2025;20:e0338337.
    >> Share

  314. EL-TANANI M, Satyam SM, Rabbani SA, El-Tanani Y, et al
    Disruption of epidermal growth factor receptor signaling and cytoskeletal dynamics by mebendazole and gefitinib synergistically impairs paracrine cytokine signaling in non-small cell lung cancer and triple-negative breast cancer Cell lines.
    PLoS One. 2025;20:e0338027.
    >> Share

  315. FENG Y, Chen W, Lu Y, Zhou H, et al
    Correlation study of brain function changes after chemotherapy in breast cancer patients by automated fiber quantification based on diffusion tensor imaging.
    PLoS One. 2025;20:e0339924.
    >> Share

  316. OEDINGEN C, Hua N, MacDonald KV, Marcadier J, et al
    To test or not to test? Study protocol for a best-worst scaling to understand decision-making and preferences for genetic testing in moderate-risk individuals.
    PLoS One. 2025;20:e0339696.
    >> Share

  317. CEESAY I, Pwavodi PC, Shittu RO, Umar H, et al
    Green synthesis of zinc oxide nanoparticles using ethanolic leaf extract of Olea europaea and its in vitro evaluation on MDA-MB-231 cancer cell lines, antibacterial and antioxidant activities.
    PLoS One. 2025;20:e0339400.
    >> Share

  318. SHENG Y, Fleming MR, Mezzanotte-Sharpe J, Hewavithana NS, et al
    A research protocol using ECG monitoring for detection of palpitations-associated arrhythmias in breast cancer survivors.
    PLoS One. 2025;20:e0338932.
    >> Share

    January 2024
  319. KUO ET, Kuo C, Lin CL
    Inhaled anesthesia associated with reduced mortality in patients with stage III breast cancer: A population-based study.
    PLoS One. 2024;19:e0289519.
    >> Share

  320. NYAMHANGA T, Eustace RW, Makoye JP, Mutalemwa K, et al
    Multi-level barriers to early detection of breast cancer among rural midlife women in Tanzania: A qualitative case study.
    PLoS One. 2024;19:e0297798.
    >> Share

  321. MILLER JL, Reddy A, Harman RM, Van de Walle GR, et al
    A xenotransplantation mouse model to study physiology of the mammary gland from large mammals.
    PLoS One. 2024;19:e0298390.
    >> Share

  322. XIA Q, Shen J, Wang Q, Chen R, et al
    Cuproptosis-associated ncRNAs predict breast cancer subtypes.
    PLoS One. 2024;19:e0299138.
    >> Share

  323. BAKER R, Dell'Acqua G, Richards A, Thornton MJ, et al
    Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines.
    PLoS One. 2024;19:e0297080.
    >> Share

  324. WIRANATA JA, Hutajulu SH, Astari YK, Leo B, et al
    Patient-reported outcomes and symptom clusters pattern of chemotherapy-induced toxicity in patients with early breast cancer.
    PLoS One. 2024;19:e0298928.
    >> Share

  325. TAOMA K, Ruengjitchatchawalya M, Liangruksa M, Laomettachit T, et al
    Boolean modeling of breast cancer signaling pathways uncovers mechanisms of drug synergy.
    PLoS One. 2024;19:e0298788.
    >> Share

  326. ABDUL REHMAN M, Tahir E, Ghulam Hussain H, Khalid A, et al
    Awareness regarding breast cancer amongst women in Pakistan: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0298275.
    >> Share

  327. WAHLSTROM E, Audisio RA, Selvaggi G
    Aspects to consider regarding breast cancer risk in trans men: A systematic review and risk management approach.
    PLoS One. 2024;19:e0299333.
    >> Share

  328. KESSLER LG, Comstock B, Aiello Bowles EJ, Mou J, et al
    Protocol to measure validity and reliability of colorectal, breast, cervical and lung cancer screening questions from the 2021 National Health Interview Survey: Methodology and design.
    PLoS One. 2024;19:e0297773.
    >> Share

  329. NGUYEN AQ, Tran OTM, Nguyen PK, Nguyen HT, et al
    Cost-effectiveness of one-year adjuvant trastuzumab therapy in treatment for early-stage breast cancer patients with HER2+ in Vietnam.
    PLoS One. 2024;19:e0300474.
    >> Share

  330. NORTHGRAVES M, Cohen J, Harvey J, Huang C, et al
    A randomised controlled trial of Pre-Operative Oncotype DX testing in early-stage breast cancer (PRE-DX study) - Study protocol.
    PLoS One. 2024;19:e0300339.
    >> Share

  331. ZHU JJ, Huang FY, Chen H, Zhang YL, et al
    Autocrine phosphatase PDP2 inhibits ferroptosis by dephosphorylating ACSL4 in the Luminal A Breast Cancer.
    PLoS One. 2024;19:e0299571.
    >> Share

  332. BELACHEW EB, Desta AF, Mulu A, Deneke DB, et al
    High rate of high-risk human papillomavirus among benign and breast cancer patients in Ethiopia.
    PLoS One. 2024;19:e0298583.
    >> Share

  333. OTTO AK, Prinsloo S, Natori A, Wagner RW, et al
    Impact of COVID-19-related experiences on health-related quality of life in cancer survivors in the United States.
    PLoS One. 2024;19:e0297077.
    >> Share

  334. NIU X, Wang J, Liu J, Yu Q, et al
    17beta-Estradiol promotes metastasis in triple-negative breast cancer through the Calpain/YAP/beta-catenin signaling axis.
    PLoS One. 2024;19:e0298184.
    >> Share

  335. EBRAHIMPOUR-KOUJAN S, Benisi-Kohansal S, Azadbakht L, Fallah M, et al
    Adherence to HEI-2010 and odds of breast cancer according to the menopause status: Evidence from Middle Eastern Country.
    PLoS One. 2024;19:e0300986.
    >> Share

  336. DEMEKE T, Hailemariam D, Santos P, Seife E, et al
    Willingness and ability to pay for breast cancer treatment among patients from Addis Ababa, Ethiopia: A cross-sectional study.
    PLoS One. 2024;19:e0300631.
    >> Share

  337. RAGHURAM GV, Pal K, Sriram G, Khan A, et al
    Correction: Therapeutic interventions on human breast cancer xenografts promote systemic dissemination of oncogenes.
    PLoS One. 2024;19:e0301650.
    >> Share


  338. Retraction: Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells.
    PLoS One. 2024;19:e0300804.
    >> Share

  339. KANG ES, Lim YC, Jang BH, Lee YJ, et al
    Changes in lymph node surgery in breast cancer and preoperative drug prescription analysis for postoperative pain management: A retrospective, cross-sectional study.
    PLoS One. 2024;19:e0298270.
    >> Share

  340. FONSECA-ALVES CE, Leis-Filho AF, Lacerda ZA, de Faria Lainetti P, et al
    Lapatinib antitumor effect is associated with PI3K and MAPK pathway: An analysis in human and canine prostate cancer cells.
    PLoS One. 2024;19:e0297043.
    >> Share

  341. ZHU K, Sui Y, Zhu M, Gao Y, et al
    Development and validation of a nomogram for predicting lymph node metastasis in ductal carcinoma in situ with microinvasion: A SEER population-based study.
    PLoS One. 2024;19:e0301057.
    >> Share

  342. ALHASSAN AM
    An improved breast cancer classification with hybrid chaotic sand cat and Remora Optimization feature selection algorithm.
    PLoS One. 2024;19:e0300622.
    >> Share

  343. SLOJEWSKA K, Galbarczyk A, Klimek M, Tubek-Krokosz A, et al
    Higher number of steps is related to lower endogenous progesterone but not estradiol levels in women.
    PLoS One. 2024;19:e0299580.
    >> Share

  344. BAHCACI U, Atasavun Uysal S, Erdogan Iyigun Z, Ordu C, et al
    Progressive relaxation training in patients with breast cancer receiving aromatase inhibitor therapy-randomized controlled trial.
    PLoS One. 2024;19:e0301020.
    >> Share

  345. ABIDI O, Abdelkafi-Koubaa Z, Bettaieb-Dridi I, Toumi L, et al
    Pistacia lentiscus L. revealed in vitro anti-proliferative activity on MCF-7 breast cancer cells and in vivo anti-mammary cancer effect on C57BL/6 mice through necrosis, anti-inflammatory and antioxidant enhancements.
    PLoS One. 2024;19:e0301524.
    >> Share

  346. ERDOGAN C, Suer I, Kaya M, Ozturk S, et al
    Bioinformatics analysis of the potentially functional circRNA-miRNA-mRNA network in breast cancer.
    PLoS One. 2024;19:e0301995.
    >> Share

  347. ALLANA A, Shamsi U, Rashid Y, Khan FR, et al
    Oral mucositis & oral health related quality of life in women undergoing chemotherapy for breast cancer in Karachi, Pakistan: A multicenter hospital based cross-sectional study.
    PLoS One. 2024;19:e0295456.
    >> Share

  348. EUM DY, Jeong M, Park SY, Kim J, et al
    AM-18002, a derivative of natural anmindenol A, enhances radiosensitivity in mouse breast cancer cells.
    PLoS One. 2024;19:e0296989.
    >> Share

  349. KIM BK, Kim B, You SH, Jang MS, et al
    Early therapy evaluation of intra-arterial trastuzumab injection in a human breast cancer xenograft model using multiparametric MR imaging.
    PLoS One. 2024;19:e0300171.
    >> Share

  350. LUKASIEWICZ-SMIETANSKA D, Godlewski D, Nowakowska E, Szpak A, et al
    Association of the bitter taste genes TAS2R38 and CA6 and breast cancer risk; a case-control study of Polish women in Poland and Polish immigrants in USA.
    PLoS One. 2024;19:e0300061.
    >> Share

  351. LEVKOVICH I, Rosman L, Signorelli C
    "Hearing the pupils' voices through my own struggles": A qualitative study of return to work among school counselors who are breast cancer survivors.
    PLoS One. 2024;19:e0300396.
    >> Share

  352. BEHR M, Alizadeh L, Buckner-Baiamonte L, Roberts B, et al
    Structured illumination microscopy for cancer identification in diagnostic breast biopsies.
    PLoS One. 2024;19:e0302600.
    >> Share

  353. VERMEHREN-SCHMAEDICK A, Peto M, Wagoner W, Chiotti KE, et al
    Mutation of SIVA, a candidate metastasis gene identified from clonally related bilateral breast cancers, promotes breast cancer cell spread in vitro and in vivo.
    PLoS One. 2024;19:e0302856.
    >> Share

  354. KAWAZU M, Saso K, Tong KI, McQuire T, et al
    Correction: Histone Demethylase JMJD2B Functions as a Co-Factor of Estrogen Receptor in Breast Cancer Proliferation and Mammary Gland Development.
    PLoS One. 2024;19:e0303780.
    >> Share

  355. SCHWARZ F, Arefian H, Hartmann M, Runnebaum I, et al
    Correction: Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany.
    PLoS One. 2024;19:e0303776.
    >> Share

  356. SUN G, Cai L, Yan X, Nie W, et al
    A prediction model based on digital breast pathology image information.
    PLoS One. 2024;19:e0294923.
    >> Share

  357. PELICANO AC, Goncalves MCT, Castela T, Orvalho ML, et al
    Repository of MRI-derived models of the breast with single and multiple benign and malignant tumors for microwave imaging research.
    PLoS One. 2024;19:e0302974.
    >> Share

  358. YANG Z, Wang Y, Huang S, Geng Y, et al
    Identification of potential anti-tumor targets and mechanisms of HuaChanSu injection using network pharmacology and cytological experiments in Breast cancer.
    PLoS One. 2024;19:e0303650.
    >> Share

  359. PINTO-CARBO M, Vanaclocha-Espi M, Ibanez J, Martin-Pozuelo J, et al
    Interaction of sedentary behaviour and educational level in breast cancer risk.
    PLoS One. 2024;19:e0300349.
    >> Share

  360. SAITO N, Matsuo T, Tsuda H, Yokota H, et al
    Novel approach to HER2 quantification using phosphor-integrated dots in human breast invasive cancer microarray.
    PLoS One. 2024;19:e0303614.
    >> Share

  361. XIAO J, Tan L, Pei Y, Yang R, et al
    Association between red cell distribution width and all-cause mortality in patients with breast cancer: A retrospective analysis using MIMIC-IV 2.0.
    PLoS One. 2024;19:e0302414.
    >> Share

  362. MUNTER-YOUNG R, Fuentes-Alburo A, DiGregorio N, Neeser K, et al
    Clinical and economic outcomes of adding [18F]FES PET/CT in estrogen receptor status identification in metastatic and recurrent breast cancer in the US.
    PLoS One. 2024;19:e0302486.
    >> Share

  363. XU Y, Yu J, Shen R, Shan X, et al
    Comparison efficacy and safety of acupuncture and moxibustion therapies in breast cancer-related lymphedema: A systematic review and network meta-analysis.
    PLoS One. 2024;19:e0303513.
    >> Share

  364. LUU TNN, Dinh DX, Tran TX, Tran TB, et al
    Health-state utility of patients with HER2-positive breast cancer in Vietnam: A multicenter cross-sectional study.
    PLoS One. 2024;19:e0303011.
    >> Share

  365. KIM SM, Park N, Park HB, Lee J, et al
    Exploring novel immunotherapy biomarker candidates induced by cancer deformation.
    PLoS One. 2024;19:e0303433.
    >> Share

  366. KHOIRUNNISA SM, Suryanegara FDA, Setiawan D, Postma MJ, et al
    Economic evaluation of trastuzumab in HER2-positive early breast cancer in Indonesia: A cost-effectiveness analysis.
    PLoS One. 2024;19:e0304483.
    >> Share

  367. RAN T, Chen J, She Q, Mu Y, et al
    Anthracycline-induced arrhythmias in breast cancer therapy: A meta-analysis of single-arm trials.
    PLoS One. 2024;19:e0303208.
    >> Share

  368. OKYERE ASANTE PG, Owusu AY, Oppong JR, Amegah KE, et al
    An assessment of the direct and indirect costs of breast cancer treatment in leading cancer hospitals in Ghana.
    PLoS One. 2024;19:e0301378.
    >> Share

  369. JOHNSON KJ, O'Connell CP, Waken RJ, Barnes JM, et al
    Impact of COVID-19 pandemic on breast cancer screening in a large midwestern United States academic medical center.
    PLoS One. 2024;19:e0303280.
    >> Share

  370. PRAMANIK P, Roy A, Cuevas E, Perez-Cisneros M, et al
    DAU-Net: Dual attention-aided U-Net for segmenting tumor in breast ultrasound images.
    PLoS One. 2024;19:e0303670.
    >> Share

  371. FU Y, Zhou J, Li J
    Diagnostic performance of ultrasound-based artificial intelligence for predicting key molecular markers in breast cancer: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0303669.
    >> Share

  372. ALASMARI A
    Achillea fragrantissima (Forssk.) Sch.Bip instigates the ROS/FADD/c-PARP expression that triggers apoptosis in breast cancer cell (MCF-7).
    PLoS One. 2024;19:e0304072.
    >> Share

  373. ZHOU K, Robert M, Seegers V, Blanc-Lapierre A, et al
    Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.
    PLoS One. 2024;19:e0304556.
    >> Share

  374. ELGHOROURY EA, Abdelghafar EE, Kamel S, Awadallah E, et al
    Dysregulation of miR-122, miR-574 and miR-375 in Egyptian patients with breast cancer.
    PLoS One. 2024;19:e0298536.
    >> Share

  375. KALSOOM A, Altaf A, Sattar H, Maqbool T, et al
    Gene expression and anticancer evaluation of Kigelia africana (Lam.) Benth. Extracts using MDA-MB-231 and MCF-7 cell lines.
    PLoS One. 2024;19:e0303134.
    >> Share

  376. CONZ L, Jales RM, Doria MT, Melloni I, et al
    Predictive value of ultrasound doppler parameters in neoadjuvant chemotherapy response of breast cancer: Prospective comparison with magnetic resonance and mammography.
    PLoS One. 2024;19:e0302527.
    >> Share

  377. TSENG TH, Chiang SC, Hsu JC, Ko Y, et al
    Cost-effectiveness analysis of granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced febrile neutropenia in patients with breast cancer in Taiwan.
    PLoS One. 2024;19:e0303294.
    >> Share

  378. TUTUIANU A, Anene CA, Shelton M, Speirs V, et al
    Platelet-derived microvesicles isolated from type-2 diabetes mellitus patients harbour an altered miRNA signature and drive MDA-MB-231 triple-negative breast cancer cell invasion.
    PLoS One. 2024;19:e0304870.
    >> Share

  379. DAVIDOVIC M, Dhokotera T, Dos-Santos-Silva I, Bohlius J, et al
    Breast cancer in women by HIV status: A report from the South African National Cancer Registry.
    PLoS One. 2024;19:e0305274.
    >> Share

  380. ALEM T, Nigatu D, Birara A, Fetene T, et al
    Quality of life of breast cancer patients in Amhara region, Ethiopia: A cross-sectional study.
    PLoS One. 2024;19:e0305263.
    >> Share

  381. REY-VARGAS L, Bejarano-Rivera LM, Serrano-Gomez SJ
    Genetic ancestry is related to potential sources of breast cancer health disparities among Colombian women.
    PLoS One. 2024;19:e0306037.
    >> Share

  382. SAMMAN N, Mohabatkar H, Behbahani M, Ganjlikhani Hakemi M, et al
    Bioinformatics design of a peptide vaccine containing sarcoma antigen NY-SAR-35 epitopes against breast cancer and evaluation of its immunological function in BALB/c mouse model.
    PLoS One. 2024;19:e0306117.
    >> Share

  383. TSUTSUMI E, Macy AM, LoBello J, Hastings KT, et al
    Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer.
    PLoS One. 2024;19:e0304194.
    >> Share

  384. GODINA C, Khazaei S, Belting M, Vallon-Christersson J, et al
    High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome.
    PLoS One. 2024;19:e0305222.
    >> Share

  385. DONG J, Wang D, Zhong S
    Effects of different exercise types and cycles on pain and quality of life in breast cancer patients: A systematic review and network meta-analysis.
    PLoS One. 2024;19:e0300176.
    >> Share

  386. LI X, Niu C, Yi G, Zhang Y, et al
    Quercetin inhibits the epithelial-mesenchymal transition and reverses CDK4/6 inhibitor resistance in breast cancer by regulating circHIAT1/miR-19a-3p/CADM2 axis.
    PLoS One. 2024;19:e0305612.
    >> Share

  387. AHMAD J, Akram S, Jaffar A, Ali Z, et al
    Deep learning empowered breast cancer diagnosis: Advancements in detection and classification.
    PLoS One. 2024;19:e0304757.
    >> Share

  388. JENKINS V, Habibi R, Hall V, Leonard P, et al
    Roll-out of an educational workshop to improve knowledge and self-confidence of healthcare professionals engaged in mainstreaming of breast cancer genetics.
    PLoS One. 2024;19:e0307301.
    >> Share

  389. GEREMEW H, Golla EB, Simegn MB, Abate A, et al
    Late-stage diagnosis: The driving force behind high breast cancer mortality in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0307283.
    >> Share

  390. WANG X, Dai Z, Zhu X, Li Y, et al
    Effects of mindfulness-based stress reduction on quality of life of breast cancer patient: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0306643.
    >> Share

  391. MON AM, Craig MacKinnon A Jr, Traktman P
    Correction: Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells.
    PLoS One. 2024;19:e0307693.
    >> Share

  392. PATRA A, Ali SS, Devi NM, Qadeer AS, et al
    Prevalence of BRCA mutation in breast and ovarian cancer among women in India: A systematic review and meta-analysis protocol.
    PLoS One. 2024;19:e0306612.
    >> Share

  393. JUNG M, Nicholas N, Grindrod S, Dritschilo A, et al
    Dual-targeting class I HDAC inhibitor and ATM activator, SP-1-303, preferentially inhibits estrogen receptor positive breast cancer cell growth.
    PLoS One. 2024;19:e0306168.
    >> Share

  394. KAMBALAPALLI S, Baral N, Paul TK, Upreti P, et al
    Thirty-day hospital readmission in females with acute heart failure and breast cancer: A retrospective cohort study from national readmission database.
    PLoS One. 2024;19:e0301596.
    >> Share

  395. BAENA-MIRET S, Reverter F, Vegas E
    A framework for block-wise missing data in multi-omics.
    PLoS One. 2024;19:e0307482.
    >> Share

  396. PATI A, Panigrahi A, Parhi M, Giri J, et al
    Performance assessment of hybrid machine learning approaches for breast cancer and recurrence prediction.
    PLoS One. 2024;19:e0304768.
    >> Share

  397. GALIN M, de Girolamo L, Clarisse B, Segura-Djezzar C, et al
    Exploration of effects of galvanic vestibular stimulation on circadian rhythms and its associations with sleep and spatial memory in patients with breast cancer: The ICANSLEEP-2 protocol.
    PLoS One. 2024;19:e0306462.
    >> Share

  398. SAJJADI SF, Salehi N, Sadeghi M
    Comprehensive integrated single-cell RNA sequencing analysis of brain metastasis and glioma microenvironment: Contrasting heterogeneity landscapes.
    PLoS One. 2024;19:e0306220.
    >> Share

  399. BAZIYAR MA, Hosseini A, Jandel F
    The role of palbociclib on the alterations in CDKN2, CCNE1, E2F3, MDM2 expressions as target genes of miR-141.
    PLoS One. 2024;19:e0306545.
    >> Share

  400. VAHED SZ, Khatibi SMH, Saadat YR, Emdadi M, et al
    Introducing effective genes in lymph node metastasis of breast cancer patients using SHAP values based on the mRNA expression data.
    PLoS One. 2024;19:e0308531.
    >> Share

  401. JOO Y, Kim MJ, Yoon JH, Rho M, et al
    Second breast cancer following negative breast MRI: Analysis by interval from surgery and risk factors.
    PLoS One. 2024;19:e0306828.
    >> Share

  402. EL HAJI H, Sbihi N, Guermah B, Souadka A, et al
    Epidemiological breast cancer prediction by country: A novel machine learning approach.
    PLoS One. 2024;19:e0308905.
    >> Share

  403. SIEBERS CCN, Appelman L, Koco L, Palm M, et al
    Patients' perceptions of targeted breast ultrasound and digital breast tomosynthesis in the diagnostic setting: A mixed methods study.
    PLoS One. 2024;19:e0308840.
    >> Share

  404. PRICE MD, Mali ME, Ernest A, Abrahams AOD, et al
    Availability and geographic access to breast cancer pathology services in Ghana.
    PLoS One. 2024;19:e0305901.
    >> Share

  405. FLEMING L, Zibaite S, Kyle SD, Boyd K, et al
    Insomnia prehabilitation in newly diagnosed breast cancer patients: Protocol for a pilot, multicentre, randomised controlled trial comparing nurse delivered sleep restriction therapy to sleep hygiene education (INVEST trial).
    PLoS One. 2024;19:e0305304.
    >> Share

  406. CHOW KM, Chan CWH, Choi KC, McCarthy AL, et al
    A multimodal couple-coping intervention for enhancing sexual adjustment among breast cancer women: Study protocol for a randomised controlled trial.
    PLoS One. 2024;19:e0309218.
    >> Share

  407. ALNOWAISER K, Saber A, Hassan E, Awad WA, et al
    An optimized model based on adaptive convolutional neural network and grey wolf algorithm for breast cancer diagnosis.
    PLoS One. 2024;19:e0304868.
    >> Share

  408. BASHIR I, Dilshad E
    A comparative study of Mentha longifolia var. asiatica and Zygophyllum arabicum ZnO nanoparticles against breast cancer targeting Rab22A gene.
    PLoS One. 2024;19:e0308982.
    >> Share

  409. VIVES N, Vidal C, de Guzman EN, Farre A, et al
    The use of text messages as an alternative invitation method for breast cancer screening: A randomized controlled trial (M-TICS study).
    PLoS One. 2024;19:e0306720.
    >> Share

  410. AB MUMIN N, Ramli Hamid MT, Wong JHD, Chiew SF, et al
    Investigation of breast cancer molecular subtype in a multi-ethnic population using MRI.
    PLoS One. 2024;19:e0309131.
    >> Share

  411. PINELLI M, Gerardi C, Lettieri E, Maioru M, et al
    Comparison of Indocyanine Green with conventional tracers for sentinel lymph node biopsy in breast cancer: A multidisciplinary evaluation of clinical effectiveness, safety, organizational and economic impact.
    PLoS One. 2024;19:e0309336.
    >> Share

  412. ODONGO D, Musisi A, Okello RO, Bongomin F, et al
    National diagnostic reference levels for digital diagnostic and screening mammography in Uganda.
    PLoS One. 2024;19:e0294541.
    >> Share

  413. THAO DT, Thanh NP, Quyen DV, Khai LT, et al
    Identification of breast cancer-associated PIK3CA H1047R mutation in blood circulation using an asymmetric PCR assay.
    PLoS One. 2024;19:e0309209.
    >> Share

  414. BAGHERMANESH SS, Barati M, Hosseini A
    The effect of ribociclib on the expression levels of miR-141 and CDK4/6-USP51 signaling pathway genes in MCF-7 and MDA-MB-231 cells.
    PLoS One. 2024;19:e0309289.
    >> Share

  415. TORRES S, Bayoumi AM, Abrahao ABK, Trudeau M, et al
    Implementing routine collection of EQ-5D-5L in a breast cancer outpatient clinic.
    PLoS One. 2024;19:e0307225.
    >> Share

  416. WATABE S, Watanabe T, Yada S, Aramaki E, et al
    Exploring a method for extracting concerns of multiple breast cancer patients in the domain of patient narratives using BERT and its optimization by domain adaptation using masked language modeling.
    PLoS One. 2024;19:e0305496.
    >> Share

  417. GUERRIERI-GONZAGA A, Serrano D, Gnagnarella P, Johansson H, et al
    Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer.
    PLoS One. 2024;19:e0309511.
    >> Share

  418. VAN STRIEN-KNIPPENBERG IS, Timmermans DRM, Engelhardt EG, Konings IRHM, et al
    Presenting decision-relevant numerical information to Dutch women aged 50-70 with varying levels of health literacy: Case example of adjuvant systemic therapy for breast cancer.
    PLoS One. 2024;19:e0309668.
    >> Share

  419. AMBRIZ-BARRERA F, Rojas-Jimenez E, Diaz-Velasquez CE, De-La-Cruz-Montoya AH, et al
    Mutational spectrum of breast cancer by shallow whole-genome sequencing of cfDNA and tumor gene panel analysis.
    PLoS One. 2024;19:e0308176.
    >> Share

  420. AYOUB NM, Sardiah S, Al-Share QY, Alkader MS, et al
    Exploring angiogenic pathways in breast cancer: Clinicopathologic correlations and prognostic implications based on gene expression profiles from a large-scale genomic dataset.
    PLoS One. 2024;19:e0310557.
    >> Share

  421. KWAN ML, Pimentel N, Izano M, Iribarren C, et al
    Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study.
    PLoS One. 2024;19:e0310531.
    >> Share

  422. HAN M, Chen H, Li J, Zheng X, et al
    Correlation between symptom experience and fear of cancer recurrence in postoperative breast cancer patients undergoing chemotherapy in China: A cross-sectional study.
    PLoS One. 2024;19:e0308907.
    >> Share

  423. HINDMARCH S, Gorman L, Usher-Smith JA, Woof VG, et al
    Development of a breast cancer risk assessment and primary prevention pathway for women aged 30-39 years: Views of UK primary care providers on the role of primary care.
    PLoS One. 2024;19:e0308638.
    >> Share

  424. KANEDA Y, Yamashita E, Saito H, Gonda K, et al
    Increasing trends of pharmaceutical payments to breast cancer specialists in Japan: A retrospective study from 2016 to 2019.
    PLoS One. 2024;19:e0310880.
    >> Share

  425. LU Q, Lun D, Dawkins-Moultin L, Li Y, et al
    Study protocol for writing to heal: A culturally based brief expressive writing intervention for Chinese immigrant breast cancer survivors.
    PLoS One. 2024;19:e0309138.
    >> Share

  426. CHEN Q, Weng Z, Lu Y, Jia Y, et al
    Correction: An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.
    PLoS One. 2024;19:e0311128.
    >> Share

  427. ALI M, Wu T, Hu H, Mahmood T, et al
    Breast tumor segmentation using neural cellular automata and shape guided segmentation in mammography images.
    PLoS One. 2024;19:e0309421.
    >> Share

  428. RAHPEIMA R, Lin CA
    A comprehensive numerical procedure for high-intensity focused ultrasound ablation of breast tumour on an anatomically realistic breast phantom.
    PLoS One. 2024;19:e0310899.
    >> Share

  429. SHIN E, Kim HM, Koo JS
    Expression of PD-L1 in breast invasive lobular carcinoma.
    PLoS One. 2024;19:e0309170.
    >> Share

  430. SUTHERLAND EK, Smith JD, Ofori-Boateng M, Kushitor SB, et al
    Study protocol for the development of a real-time interface showing the availability of breast and cervical cancer services in Ghana.
    PLoS One. 2024;19:e0312150.
    >> Share

  431. LI B, Li X, Liu J, Gao Y, et al
    Immunocyte phenotype and breast cancer risk: A Mendel randomization analysis.
    PLoS One. 2024;19:e0311172.
    >> Share

  432. FIRATLIGIL-YILDIRIR B, Bati-Ayaz G, Nonappa, Pesen-Okvur D, et al
    Invasion/chemotaxis- and extravasation-chip models for breast cancer bone metastasis.
    PLoS One. 2024;19:e0309285.
    >> Share

  433. YU H, Peng Z, Li X, Zhang Y, et al
    Establishment of a tumor-associated fibroblast associated gene score based on scRNA-seq to predict prognosis in patients with triple-negative breast cancer.
    PLoS One. 2024;19:e0311801.
    >> Share

  434. AL-ATIYYAT N, Salem HF, Hamam AHM
    Impact of pain on functional status and quality of life in Jordanian women with breast cancer.
    PLoS One. 2024;19:e0307271.
    >> Share

  435. ADDISU S, Bekele A, Seifu D, Assefa M, et al
    Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor A (VEGF-A) expressions in Ethiopian female breast cancer and their association with histopathologic features.
    PLoS One. 2024;19:e0308411.
    >> Share

  436. LEE MK, Levine NT, Hayes LR, Shields CG, et al
    Navigating the cancer care continuum: A comparative study of Black and White breast cancer patients.
    PLoS One. 2024;19:e0312547.
    >> Share

  437. WU Y, Miller ME, Gilmore HL, Thompson CL, et al
    Epigenetic aging differentially impacts breast cancer risk by self-reported race.
    PLoS One. 2024;19:e0308174.
    >> Share

  438. OHKAWA K, Nakabori T, Mukai K, Kozumi K, et al
    Clinical validation of the suppressive impact of letrozole on liver fibrosis in patients with breast cancer undergoing continuous letrozole administration: A retrospective study.
    PLoS One. 2024;19:e0311930.
    >> Share

  439. KAUTZ-FREIMUTH S, Lautz Z, Shukri A, Redaelli M, et al
    Decisional conflict and knowledge in women with BRCA1/2 pathogenic variants: An exploratory age group analysis of a randomised controlled decision aid trial.
    PLoS One. 2024;19:e0311432.
    >> Share

  440. PANDIYAN A, Lari S, Vanka J, Kumar BS, et al
    Plasma pesticide residues-serum 8-OHdG among farmers/non-farmers diagnosed with lymphoma, leukaemia and breast cancers: A case-control study.
    PLoS One. 2024;19:e0295625.
    >> Share

  441. ANH NK, Lee A, Phat NK, Yen NTH, et al
    Combining metabolomics and machine learning to discover biomarkers for early-stage breast cancer diagnosis.
    PLoS One. 2024;19:e0311810.
    >> Share

  442. MING Y, Yang F, Xiao Y, Yue S, et al
    Exploring the feasibility of FOCUS DWI with deep learning reconstruction for breast cancer diagnosis: A comparative study with conventional DWI.
    PLoS One. 2024;19:e0313011.
    >> Share

  443. KIM JW, Bae SH, Moon Y, Kim EK, et al
    Transcriptomic analysis of cellular senescence induced by ectopic expression of ATF6alpha in human breast cancer cells.
    PLoS One. 2024;19:e0309749.
    >> Share

  444. SILVA MA, Williams S, Hauert S, Ovadia B, et al
    Tumour assessment of ROR1 levels in various adult leukaemia and lymphoma types.
    PLoS One. 2024;19:e0313026.
    >> Share

  445. TIBENDERANA JR, Kessy SA, Mlaponi DF, Mwaitete NL, et al
    Predictors of breast cancer screening among women of reproductive age in Tanzania: Evidence from DHS 2022.
    PLoS One. 2024;19:e0298996.
    >> Share

  446. ZHANG H, Liang H, Wenjia G, Jing M, et al
    ACL-DUNet: A tumor segmentation method based on multiple attention and densely connected breast ultrasound images.
    PLoS One. 2024;19:e0307916.
    >> Share

  447. LAI H, Liu Y, Gong Y, Zong C, et al
    Expression of SIGLEC15 correlates with tumor immune infiltration, molecular subtypes, and breast cancer progression.
    PLoS One. 2024;19:e0313561.
    >> Share

  448. BAWALLE AA, Nguyen TXT, Khan MSR, Kadoya Y, et al
    Impact of financial literacy and education on breast and cervical cancer screening participation in Japan.
    PLoS One. 2024;19:e0313687.
    >> Share

  449. MULUGETA C, Emagneneh T, Kumie G, Ejigu B, et al
    Delayed presentation of breast cancer patients and contributing factors in East Africa: Systematic review and meta-analysis.
    PLoS One. 2024;19:e0309792.
    >> Share

  450. FIGALLO M, Delgado MF, Gonzalez M, Arenas A, et al
    Cost minimization analysis of treatments for metastatic HER2-positive breast cancer in Peru: Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injections.
    PLoS One. 2024;19:e0295730.
    >> Share

  451. CHUTOE C, Inson I, Krobthong S, Phueakphud N, et al
    Combinatorial effects of cannabinoid receptor 1 and 2 agonists on characteristics and proteomic alteration in MDA-MB-231 breast cancer cells.
    PLoS One. 2024;19:e0312851.
    >> Share

  452. SONG W, Shari NI, Song J, Zhang R, et al
    Effectiveness of Acceptance and Commitment Therapy (ACT) on disease acceptance for breast cancer patients: Study protocol of a randomized controlled trial.
    PLoS One. 2024;19:e0312669.
    >> Share

  453. ZILENAITE-PETRULAITIENE D, Rasmusson A, Valkiuniene RB, Laurinaviciene A, et al
    Spatial distributions of CD8 and Ki67 cells in the tumor microenvironment independently predict breast cancer-specific survival in patients with ER+HER2- and triple-negative breast carcinoma.
    PLoS One. 2024;19:e0314364.
    >> Share

  454. ADHAM SA, Al Kalbani A, Al Zeheimi N, Al Dalali M, et al
    Glycemic load impacts the response of acquired resistance in breast cancer cells to chemotherapeutic drugs in vitro.
    PLoS One. 2024;19:e0311345.
    >> Share

  455. FANIZZI A, Bove S, Comes MC, Di Benedetto EF, et al
    Prediction of breast cancer Invasive Disease Events using transfer learning on clinical data as image-form.
    PLoS One. 2024;19:e0312036.
    >> Share

  456. BOTELHO R, Kirstein CL, Philpot RM
    Cyclophosphamide- and doxorubicin-induced impairment of high affinity choline uptake and spatial memory can be prevented by dietary choline supplementation in breast tumor bearing mice.
    PLoS One. 2024;19:e0305365.
    >> Share

  457. HSU SN, Hui EWE, Liu M, Wu D, et al
    Correction: Revealing nuclear receptor hub modules from Basal-like breast cancer expression networks.
    PLoS One. 2024;19:e0314424.
    >> Share

  458. CHANG CH, Lee YC, Huang CW, Lu YM, et al
    Is tamoxifen good enough for the Asian population in ER+ HER2- post-menopausal women with early breast cancer? A nationwide population-based cohort study.
    PLoS One. 2024;19:e0313120.
    >> Share

  459. KIBRIA MK, Ali MA, Mollah MNH
    Exploring bacterial key genes and therapeutic agents for breast cancer among the Ghanaian female population: Insights from In Silico analyses.
    PLoS One. 2024;19:e0312493.
    >> Share

  460. AKINGBADE O, Hong KY, Ayo OS, Alade AS, et al
    Development and feasibility of an mHealth intervention for psychoeducational support of Nigerian women diagnosed with breast cancer undergoing chemotherapy: A pilot randomized controlled trial.
    PLoS One. 2024;19:e0314365.
    >> Share

  461. WASSIE M, Zegeye AF, Aemro A, Terefe B, et al
    Awareness and its determinant factors towards breast examination to detect breast cancer among reproductive age women in Kenya: Multi level analysis of the recent demographic and health survey data.
    PLoS One. 2024;19:e0314700.
    >> Share

  462. JHA A, Chaudhary RK, Shrivastav S, Khanal U, et al
    Ultrasonographic and pathological correlation of asymmetric retroareolar density on mammogram.
    PLoS One. 2024;19:e0301180.
    >> Share

  463. LOKTIONOVA MV, Mohammadian M, Choopani R, Kheiri S, et al
    Investigating the relationship between insulin use and all-cause mortality, breast cancer mortality, and recurrence risk in diabetic patients with breast cancer: A comprehensive systematic review and meta-analysis.
    PLoS One. 2024;19:e0314565.
    >> Share


  464. Correction: BCR-Net: A deep learning framework to predict breast cancer recurrence from histopathology images.
    PLoS One. 2024;19:e0315419.
    >> Share

  465. CAPAR A, Ekinci DA, Ertano M, Niazi MKK, et al
    An interpretable framework for inter-observer agreement measurements in TILs scoring on histopathological breast images: A proof-of-principle study.
    PLoS One. 2024;19:e0314450.
    >> Share

  466. DONG F, Li J, Wang J, Yang X, et al
    Diagnostic performance of DCE-MRI radiomics in predicting axillary lymph node metastasis in breast cancer patients: A meta-analysis.
    PLoS One. 2024;19:e0314653.
    >> Share

  467. SCHRODER AK, Loy CJ, Aiala F, Rafique J, et al
    miR-379-5p affects breast cancer cell behavior by targeting UBE2E3 ubiquitin conjugating enzyme.
    PLoS One. 2024;19:e0310315.
    >> Share

  468. MENDIVELSO-GONZALEZ DF, Clavijo Cabezas D, Montoya L, Plazas Vargas M, et al
    HER2-low prevalence among Hispanic/Latino women with breast cancer: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0315287.
    >> Share

  469. BUNNELL A, Hung K, Shepherd JA, Sadowski P, et al
    BUSClean: Open-source software for breast ultrasound image pre-processing and knowledge extraction for medical AI.
    PLoS One. 2024;19:e0315434.
    >> Share

  470. FANG Q, Fang Q, Cheng R, Feng T, et al
    CAPE activates AMPK and Foxo3 signaling to induce growth inhibition and ferroptosis in triple-negative breast cancer.
    PLoS One. 2024;19:e0315037.
    >> Share

  471. LEMMA SEIFU B, Mekuria Negussie Y, Abrham Asnake A, Daba Chinkey F, et al
    Determinants of breast cancer screening among women of reproductive age in sub-Saharan Africa: A multilevel analysis.
    PLoS One. 2024;19:e0312831.
    >> Share

  472. AMER NN, Khairat R, Hammad AM, Kamel MM, et al
    Correction: DDX43 mRNA expression and protein levels in relation to clinicopathological profile of breast cancer.
    PLoS One. 2024;19:e0316591.
    >> Share

  473. ZHANG W, Huang Y, Zhou Y, Xue J, et al
    Delving into female breast cancer: Distinct disease-specific survival outcomes between invasive lobular and ductal carcinomas revealed by propensity score matching.
    PLoS One. 2024;19:e0300116.
    >> Share

  474. TRAN TTQ, Pham TT, Nguyen TT, Hien Do T, et al
    An appropriate DNA input for bisulfite conversion reveals LINE-1 and Alu hypermethylation in tissues and circulating cell-free DNA from cancers.
    PLoS One. 2024;19:e0316394.
    >> Share

  475. KIM J, Lee J, Kim B, Kim S, et al
    Generation of deep learning based virtual non-contrast CT using dual-layer dual-energy CT and its application to planning CT for radiotherapy.
    PLoS One. 2024;19:e0316099.
    >> Share

    January 2023
  476. LAFI Z, Alshaer W, Gharaibeh L, Alqudah DA, et al
    Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line.
    PLoS One. 2023;18:e0291981.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016